CA3170947A1 - Liquid composition of h2o2 and a poloxamer for cleanining,sanitizing,and/or disinfecting - Google Patents
Liquid composition of h2o2 and a poloxamer for cleanining,sanitizing,and/or disinfecting Download PDFInfo
- Publication number
- CA3170947A1 CA3170947A1 CA3170947A CA3170947A CA3170947A1 CA 3170947 A1 CA3170947 A1 CA 3170947A1 CA 3170947 A CA3170947 A CA 3170947A CA 3170947 A CA3170947 A CA 3170947A CA 3170947 A1 CA3170947 A1 CA 3170947A1
- Authority
- CA
- Canada
- Prior art keywords
- composition according
- pluronic
- antimicrobial
- composition
- poloxamer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 190
- 229920001983 poloxamer Polymers 0.000 title claims abstract description 123
- 238000011012 sanitization Methods 0.000 title claims abstract description 62
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 229960000502 poloxamer Drugs 0.000 title claims abstract description 16
- 230000000249 desinfective effect Effects 0.000 title claims abstract description 14
- 239000007788 liquid Substances 0.000 title description 35
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 60
- 238000004140 cleaning Methods 0.000 claims abstract description 59
- 230000000840 anti-viral effect Effects 0.000 claims abstract description 43
- 239000004599 antimicrobial Substances 0.000 claims abstract description 28
- 239000012620 biological material Substances 0.000 claims abstract description 25
- 239000000017 hydrogel Substances 0.000 claims abstract description 24
- 238000009472 formulation Methods 0.000 claims abstract description 22
- 230000001954 sterilising effect Effects 0.000 claims abstract description 16
- 239000002131 composite material Substances 0.000 claims abstract description 10
- 229940121357 antivirals Drugs 0.000 claims abstract description 6
- 239000002253 acid Substances 0.000 claims description 61
- 241000700605 Viruses Species 0.000 claims description 59
- 239000000243 solution Substances 0.000 claims description 59
- 241000894006 Bacteria Species 0.000 claims description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 46
- 229910001868 water Inorganic materials 0.000 claims description 46
- 238000000034 method Methods 0.000 claims description 29
- 210000004877 mucosa Anatomy 0.000 claims description 25
- 239000000126 substance Substances 0.000 claims description 18
- 229920001992 poloxamer 407 Polymers 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 14
- 241000711573 Coronaviridae Species 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 11
- 230000000975 bioactive effect Effects 0.000 claims description 9
- 239000002504 physiological saline solution Substances 0.000 claims description 4
- 229940044476 poloxamer 407 Drugs 0.000 claims description 4
- 241001263478 Norovirus Species 0.000 claims description 3
- 241000712464 Orthomyxoviridae Species 0.000 claims description 3
- 241000702670 Rotavirus Species 0.000 claims description 3
- 150000002500 ions Chemical class 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 230000002285 radioactive effect Effects 0.000 claims description 3
- 150000003384 small molecules Chemical class 0.000 claims description 3
- 241000714198 Caliciviridae Species 0.000 claims description 2
- 241000712431 Influenza A virus Species 0.000 claims description 2
- 241000713196 Influenza B virus Species 0.000 claims description 2
- 241000713297 Influenza C virus Species 0.000 claims description 2
- 241000702247 Reoviridae Species 0.000 claims description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract description 91
- 239000007943 implant Substances 0.000 abstract description 48
- 208000027418 Wounds and injury Diseases 0.000 abstract description 24
- 230000036541 health Effects 0.000 abstract description 9
- 239000002324 mouth wash Substances 0.000 abstract description 8
- 208000025865 Ulcer Diseases 0.000 abstract description 6
- 231100000397 ulcer Toxicity 0.000 abstract description 6
- 230000001684 chronic effect Effects 0.000 abstract description 5
- 229940051866 mouthwash Drugs 0.000 abstract description 5
- 238000011321 prophylaxis Methods 0.000 abstract description 4
- 238000012423 maintenance Methods 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 55
- 150000002978 peroxides Chemical class 0.000 description 47
- 210000003491 skin Anatomy 0.000 description 47
- 239000000693 micelle Substances 0.000 description 43
- 239000000499 gel Substances 0.000 description 38
- 238000012360 testing method Methods 0.000 description 38
- 235000019441 ethanol Nutrition 0.000 description 33
- 210000000214 mouth Anatomy 0.000 description 30
- 210000001519 tissue Anatomy 0.000 description 27
- 108090000623 proteins and genes Proteins 0.000 description 26
- 102000004169 proteins and genes Human genes 0.000 description 26
- 206010052428 Wound Diseases 0.000 description 24
- 239000001301 oxygen Substances 0.000 description 24
- 229910052760 oxygen Inorganic materials 0.000 description 24
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 23
- 230000000694 effects Effects 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 17
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 16
- 230000015572 biosynthetic process Effects 0.000 description 16
- 238000011065 in-situ storage Methods 0.000 description 16
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 15
- 229960003260 chlorhexidine Drugs 0.000 description 15
- 239000003599 detergent Substances 0.000 description 15
- 239000000356 contaminant Substances 0.000 description 14
- 210000003811 finger Anatomy 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
- 210000004247 hand Anatomy 0.000 description 13
- 244000005700 microbiome Species 0.000 description 13
- 239000011780 sodium chloride Substances 0.000 description 13
- 230000003612 virological effect Effects 0.000 description 13
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 12
- 230000002068 genetic effect Effects 0.000 description 12
- 238000002156 mixing Methods 0.000 description 12
- 208000015181 infectious disease Diseases 0.000 description 11
- 239000013642 negative control Substances 0.000 description 11
- 239000010936 titanium Substances 0.000 description 11
- 229910052719 titanium Inorganic materials 0.000 description 11
- 239000003921 oil Substances 0.000 description 10
- 230000003239 periodontal effect Effects 0.000 description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 208000006389 Peri-Implantitis Diseases 0.000 description 9
- 239000003443 antiviral agent Substances 0.000 description 9
- 238000011109 contamination Methods 0.000 description 9
- 230000007547 defect Effects 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 239000000344 soap Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 241000191963 Staphylococcus epidermidis Species 0.000 description 8
- 229910002092 carbon dioxide Inorganic materials 0.000 description 8
- 230000000813 microbial effect Effects 0.000 description 8
- 230000009471 action Effects 0.000 description 7
- 239000001569 carbon dioxide Substances 0.000 description 7
- 239000004053 dental implant Substances 0.000 description 7
- 239000000839 emulsion Substances 0.000 description 7
- 238000005187 foaming Methods 0.000 description 7
- 239000003642 reactive oxygen metabolite Substances 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 6
- 241000194017 Streptococcus Species 0.000 description 6
- 229940045971 anti bac Drugs 0.000 description 6
- 229920001400 block copolymer Polymers 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 230000007613 environmental effect Effects 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 239000011368 organic material Substances 0.000 description 6
- 201000001245 periodontitis Diseases 0.000 description 6
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 206010028116 Mucosal inflammation Diseases 0.000 description 5
- 201000010927 Mucositis Diseases 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000007844 bleaching agent Substances 0.000 description 5
- 239000006260 foam Substances 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 210000003928 nasal cavity Anatomy 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 241000233866 Fungi Species 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 208000002847 Surgical Wound Diseases 0.000 description 4
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
- 208000036142 Viral infection Diseases 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 208000002925 dental caries Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 230000009385 viral infection Effects 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- 241001678559 COVID-19 virus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000007513 acids Chemical group 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000006143 cell culture medium Substances 0.000 description 3
- 238000005202 decontamination Methods 0.000 description 3
- 230000003588 decontaminative effect Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 208000007565 gingivitis Diseases 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 210000005260 human cell Anatomy 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 210000004936 left thumb Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 210000002850 nasal mucosa Anatomy 0.000 description 3
- 230000004962 physiological condition Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 3
- 229940048086 sodium pyrophosphate Drugs 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 239000008399 tap water Substances 0.000 description 3
- 235000020679 tap water Nutrition 0.000 description 3
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 3
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 239000004034 viscosity adjusting agent Substances 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 241000203069 Archaea Species 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 244000004281 Eucalyptus maculata Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010048685 Oral infection Diseases 0.000 description 2
- 229920000463 Poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) Polymers 0.000 description 2
- 241001509393 Porphyromonas cangingivalis Species 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- 241000711798 Rabies lyssavirus Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- 239000004141 Sodium laurylsulphate Substances 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- FENRSEGZMITUEF-ATTCVCFYSA-E [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] FENRSEGZMITUEF-ATTCVCFYSA-E 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960003022 amoxicillin Drugs 0.000 description 2
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 210000004666 bacterial spore Anatomy 0.000 description 2
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 229960003722 doxycycline Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000012678 infectious agent Substances 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000011418 maintenance treatment Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 150000002926 oxygen Chemical class 0.000 description 2
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- -1 pluronic acid Chemical compound 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 206010039083 rhinitis Diseases 0.000 description 2
- 210000004935 right thumb Anatomy 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 229940083982 sodium phytate Drugs 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- 210000004215 spore Anatomy 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 230000003253 viricidal effect Effects 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- RPAJSBKBKSSMLJ-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;hydrochloride Chemical class Cl.OC(=O)[C@@H](N)CCC(O)=O RPAJSBKBKSSMLJ-DFWYDOINSA-N 0.000 description 1
- WZRJTRPJURQBRM-UHFFFAOYSA-N 4-amino-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1.COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 WZRJTRPJURQBRM-UHFFFAOYSA-N 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 241000186066 Actinomyces odontolyticus Species 0.000 description 1
- 241000186044 Actinomyces viscosus Species 0.000 description 1
- 206010001076 Acute sinusitis Diseases 0.000 description 1
- 241000606749 Aggregatibacter actinomycetemcomitans Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 241000589996 Campylobacter rectus Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical class ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010009137 Chronic sinusitis Diseases 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000037408 Device failure Diseases 0.000 description 1
- 206010056340 Diabetic ulcer Diseases 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 241000588878 Eikenella corrodens Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- 241000605986 Fusobacterium nucleatum Species 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000005230 Leg Ulcer Diseases 0.000 description 1
- 244000011376 Leptospermum laevigatum Species 0.000 description 1
- 235000017865 Leptospermum laevigatum Nutrition 0.000 description 1
- 239000004907 Macro-emulsion Substances 0.000 description 1
- 241000712079 Measles morbillivirus Species 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010028735 Nasal congestion Diseases 0.000 description 1
- 208000026344 Nasal disease Diseases 0.000 description 1
- 208000030880 Nose disease Diseases 0.000 description 1
- 244000227633 Ocotea pretiosa Species 0.000 description 1
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 241001464887 Parvimonas micra Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241000605894 Porphyromonas Species 0.000 description 1
- 241000605861 Prevotella Species 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 206010039105 Rhinoviral infections Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241000580858 Simian-Human immunodeficiency virus Species 0.000 description 1
- 206010040742 Sinus congestion Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- 241000589970 Spirochaetales Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000122973 Stenotrophomonas maltophilia Species 0.000 description 1
- 241000194026 Streptococcus gordonii Species 0.000 description 1
- 241001134658 Streptococcus mitis Species 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000193987 Streptococcus sobrinus Species 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 241001135235 Tannerella forsythia Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 241000589892 Treponema denticola Species 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 241001148134 Veillonella Species 0.000 description 1
- 241001464837 Viridiplantae Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229920000469 amphiphilic block copolymer Polymers 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000003373 anti-fouling effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000007621 bhi medium Substances 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000032770 biofilm formation Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000012925 biological evaluation Methods 0.000 description 1
- 230000002599 biostatic effect Effects 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229940078916 carbamide peroxide Drugs 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 208000003796 chancre Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002925 chemical effect Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 208000027157 chronic rhinosinusitis Diseases 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 229960003324 clavulanic acid Drugs 0.000 description 1
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000001750 dental cementum Anatomy 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 210000004262 dental pulp cavity Anatomy 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000001236 detergent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- TVQLLNFANZSCGY-UHFFFAOYSA-N disodium;dioxido(oxo)tin Chemical compound [Na+].[Na+].[O-][Sn]([O-])=O TVQLLNFANZSCGY-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 235000021472 generally recognized as safe Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 238000007455 ileostomy Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 208000037799 influenza C Diseases 0.000 description 1
- 208000037800 influenza D Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000004393 laryngeal mucosa Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 230000003641 microbiacidal effect Effects 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000002346 musculoskeletal system Anatomy 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 208000003154 papilloma Diseases 0.000 description 1
- 210000003695 paranasal sinus Anatomy 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000004261 periodontium Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000006833 reintegration Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- OHRURASPPZQGQM-GCCNXGTGSA-N romidepsin Chemical group O1C(=O)[C@H](C(C)C)NC(=O)C(=C/C)/NC(=O)[C@H]2CSSCC\C=C\[C@@H]1CC(=O)N[C@H](C(C)C)C(=O)N2 OHRURASPPZQGQM-GCCNXGTGSA-N 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 229940079864 sodium stannate Drugs 0.000 description 1
- JUJBNYBVVQSIOU-UHFFFAOYSA-M sodium;4-[2-(4-iodophenyl)-3-(4-nitrophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].C1=CC([N+](=O)[O-])=CC=C1N1[N+](C=2C=CC(I)=CC=2)=NC(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)=N1 JUJBNYBVVQSIOU-UHFFFAOYSA-M 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003330 sporicidal effect Effects 0.000 description 1
- 229940071182 stannate Drugs 0.000 description 1
- 125000005402 stannate group Chemical group 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229940006995 sulfamethoxazole and trimethoprim Drugs 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 150000003608 titanium Chemical class 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/90—Block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Detergent Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Aspects of the present invention relate to an improved antimicrobial and/or anti-viral composition comprising an antimicrobial and/or anti viral mixture consisting of: H2O2 at a final concentration of between 3 - 7%v/v, and a poloxamer at a concentration of 0.1-10%w/v. The poloxamer is in a composite hydrogel formulation. The composition disclosed herein is antimicrobial and/or anti-viral and is particularly useful for cleaning, sterilizing, disinfecting, sanitizing, decontaminating and/or debriding biological surfaces and surfaces of biomaterials, such as when provided in a hand sanitizer, mouth wash, nasal rinse and/or for wound care and/or chronic ulcer care and use for dental prophylaxis and peri-implant health maintenance.
Description
IMPROVED LIQUID COMPOSITION FOR CLEANING, SANITIZING AND/OR
DISINFECTING
FIELD
Aspects of the present invention relate to multifunctional cleaning and/or antifouling compositions comprising H202 and a composite hydrogel formulation of pluronic acid, wherein the composition is in liquid form at room temperature. The compositions described herein inhibit microbes and inflammation in a subject and are particularly useful for dermal sanitizing, oral-laryngeal sanitizing, nasal sanitizing, in oral prophylaxis and periimplantitis treatment, implant health maintenance, in periodontitis and periodontal health, in wound care or chronic ulcer care.
BACKGROUND
Biological surfaces like skin and mucosa and/or biomaterial surfaces are in constant contact with and frequently colonized by a plethora of microorganisms and virus. They therefore frequently require cleaning and/or sanitizing with compositions that are antibacterial and/or antiviral without causing harm to the biological tissue in question and preferably without causing microbial and/or viral resistance.
In particular, the skin of the body, such as but not limited to on the hands, the feet, or the face is often exposed to microorganisms and needs to be cleaned, sterilized and/or sanitized regularly to inhibit settlement and/or transfer of pathogens and/or microbes and/or viruses.
Hand sanitizers A hand sanitizer is a liquid or gel, typically used to decrease infectious agents on the hands.
Formulations of the alcohol-based type are preferable to hand washing with soap and water in most situations in the healthcare setting. It is generally more effective at killing microorganisms and often better tolerated than soap and water. They are typically available as liquids, gels, wipes and/or foams.
Alcohol-based versions typically contain some combination of isopropyl alcohol, ethanol (ethyl alcohol), or n-propanol. Versions that contain 60 to 95% alcohol are considered most effective. Hand sanitizers containing at least 60% alcohol or containing a "persistent antiseptic" kill many different kinds of bacteria, including antibiotic resistant bacteria and TB
bacteria, but are less effective against virus.
In general, alcohol-based hand sanitizers inhibit a variety of microorganisms but not spores.
Some versions contain compounds such as glycerol to prevent drying of the skin. Non-
DISINFECTING
FIELD
Aspects of the present invention relate to multifunctional cleaning and/or antifouling compositions comprising H202 and a composite hydrogel formulation of pluronic acid, wherein the composition is in liquid form at room temperature. The compositions described herein inhibit microbes and inflammation in a subject and are particularly useful for dermal sanitizing, oral-laryngeal sanitizing, nasal sanitizing, in oral prophylaxis and periimplantitis treatment, implant health maintenance, in periodontitis and periodontal health, in wound care or chronic ulcer care.
BACKGROUND
Biological surfaces like skin and mucosa and/or biomaterial surfaces are in constant contact with and frequently colonized by a plethora of microorganisms and virus. They therefore frequently require cleaning and/or sanitizing with compositions that are antibacterial and/or antiviral without causing harm to the biological tissue in question and preferably without causing microbial and/or viral resistance.
In particular, the skin of the body, such as but not limited to on the hands, the feet, or the face is often exposed to microorganisms and needs to be cleaned, sterilized and/or sanitized regularly to inhibit settlement and/or transfer of pathogens and/or microbes and/or viruses.
Hand sanitizers A hand sanitizer is a liquid or gel, typically used to decrease infectious agents on the hands.
Formulations of the alcohol-based type are preferable to hand washing with soap and water in most situations in the healthcare setting. It is generally more effective at killing microorganisms and often better tolerated than soap and water. They are typically available as liquids, gels, wipes and/or foams.
Alcohol-based versions typically contain some combination of isopropyl alcohol, ethanol (ethyl alcohol), or n-propanol. Versions that contain 60 to 95% alcohol are considered most effective. Hand sanitizers containing at least 60% alcohol or containing a "persistent antiseptic" kill many different kinds of bacteria, including antibiotic resistant bacteria and TB
bacteria, but are less effective against virus.
In general, alcohol-based hand sanitizers inhibit a variety of microorganisms but not spores.
Some versions contain compounds such as glycerol to prevent drying of the skin. Non-
2 alcohol-based versions may contain benzalkonium chloride, chlorhexidine gluconate or triclosan. Care should be taken as they are flammable.
Alcohol-based hand sanitizers have been commonly used in Europe since at least the 1980s. The alcohol-based version is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.
The wholesale cost in the developing world is about US$1.40-3.70 per bottle.
One well documented draw-back with commercially available hand-sanitizers is that the alcohol in hand sanitizers may not have the 10-15 seconds exposure time required to denature proteins and lyse cells. Further, it is often applied in too low quantities (0.3 ml) or in too low concentrations. In environments with high lipids or protein waste (such as food processing), the use of alcohol hand rubs alone may not be sufficient to ensure proper hand hygiene.
To solve this, there are new alcohol gel sanitizers marketed as alcohol rub sanitizers, which kill most bacteria, and fungi, and stop some viruses. Alcohol rub sanitizers containing at least 70% alcohol (mainly ethyl alcohol) kill 99.9% of the bacteria on hands 30 seconds after application and 99.99% to 99.999% in one minute. Still, they are notably less effective against virus.
90% alcohol rubs are more effective against viruses than most other forms of hand washing.
Isopropyl alcohol will also kill 99.99 % or more of all non-spore forming bacteria in less than seconds, both in the laboratory and on human skin. 90% alcohol rubs are highly 25 flammable and have a potential for abuse, but are necessary to use to kill especially viruses, including enveloped viruses such as the flu virus, the common cold virus, coronaviruses, and HIV, though is notably ineffective against the rabies virus.
Hydrogen peroxide 30 Hydrogen peroxide (H202) is a very pale blue liquid which appears colourless in a dilute solution, slightly more viscous than water. It is a weak acid. It has strong oxidizing properties and is therefore a powerful bleaching agent that is mostly used for bleaching paper but has also found use as a disinfectant and as an oxidizer. Hydrogen peroxide in the form of carbamide peroxide is widely used for tooth whitening (bleaching), both in professionally-and in self-administered products.
Hydrogen peroxide is unstable and slowly decomposes in the presence of light.
Because of its instability, hydrogen peroxide is typically stored with a stabilizer, typically organophosphates, sodium pyrophosphate, sodium phytate or sodium citrate, in a weakly acidic solution in a dark coloured bottle.
Alcohol-based hand sanitizers have been commonly used in Europe since at least the 1980s. The alcohol-based version is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.
The wholesale cost in the developing world is about US$1.40-3.70 per bottle.
One well documented draw-back with commercially available hand-sanitizers is that the alcohol in hand sanitizers may not have the 10-15 seconds exposure time required to denature proteins and lyse cells. Further, it is often applied in too low quantities (0.3 ml) or in too low concentrations. In environments with high lipids or protein waste (such as food processing), the use of alcohol hand rubs alone may not be sufficient to ensure proper hand hygiene.
To solve this, there are new alcohol gel sanitizers marketed as alcohol rub sanitizers, which kill most bacteria, and fungi, and stop some viruses. Alcohol rub sanitizers containing at least 70% alcohol (mainly ethyl alcohol) kill 99.9% of the bacteria on hands 30 seconds after application and 99.99% to 99.999% in one minute. Still, they are notably less effective against virus.
90% alcohol rubs are more effective against viruses than most other forms of hand washing.
Isopropyl alcohol will also kill 99.99 % or more of all non-spore forming bacteria in less than seconds, both in the laboratory and on human skin. 90% alcohol rubs are highly 25 flammable and have a potential for abuse, but are necessary to use to kill especially viruses, including enveloped viruses such as the flu virus, the common cold virus, coronaviruses, and HIV, though is notably ineffective against the rabies virus.
Hydrogen peroxide 30 Hydrogen peroxide (H202) is a very pale blue liquid which appears colourless in a dilute solution, slightly more viscous than water. It is a weak acid. It has strong oxidizing properties and is therefore a powerful bleaching agent that is mostly used for bleaching paper but has also found use as a disinfectant and as an oxidizer. Hydrogen peroxide in the form of carbamide peroxide is widely used for tooth whitening (bleaching), both in professionally-and in self-administered products.
Hydrogen peroxide is unstable and slowly decomposes in the presence of light.
Because of its instability, hydrogen peroxide is typically stored with a stabilizer, typically organophosphates, sodium pyrophosphate, sodium phytate or sodium citrate, in a weakly acidic solution in a dark coloured bottle.
3 Hydrogen peroxide may be used for the sterilization of various surfaces, including surgical tools and may be deployed as a vapour (VHP) for room sterilization. H202 demonstrates broad-spectrum efficacy against virus and microbes including, but not limited to, bacteria, yeasts, and bacterial spores. In general, greater activity is seen against Gram-positive than Gram-negative bacteria though; however, the presence of catalase or other peroxidases in these organisms may increase tolerance in the presence of lower concentrations. Higher concentrations of H202 (10 to 30%v/v) and longer contact times are sometimes required for sporicidal activity.
Hydrogen peroxide is seen as an environmentally safe alternative to chlorine-based bleaches, as it degrades to form oxygen and water and is generally recognized as safe as an antimicrobial agent by the U.S. Food and Drug Administration (FDA).
Historically, hydrogen peroxide was used for disinfecting wounds. Today, it is thought to inhibit healing and to induce scarring, because it destroys newly formed skin cells at high concentrations. This is understood to be caused by the drying-out effect of peroxide.
One study found that only very low concentrations (0.03%v/v solution, this is a dilution of typical 3%v/v Peroxide by 100 times) may induce healing, and only if not applied repeatedly.
A 0.5%v/v solution was found to impede healing. Recently, new studies have however shown that peroxide is an important and intrinsic part of the cellular signalling and defence system, generating a signal that activates local defence cells in response to infections and insults. In line with this it is also now known that cells employ peroxide directly to kill microbes and virus in their immediate vicinity. Because of this knowledge, peroxide has gained renewed attention as a biologically active sanitizing substance.
Pluronic acid Pluronics0 or poloxamers are tri-block copolymers of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO). This group of synthetic polymers is thermo-reversible in aqueous solutions. The sol-gel transition is governed by the composition, molecular weight and concentration of each constituent block polymer. The hydrophilic ethylene oxide and the hydrophobic propylene oxide give pluronics an amphiphilic structure ¨ meaning it has a polar, water-soluble group attached to a nonpolar water-insoluble hydrocarbon chain. Amphiphilic block copolymer molecules self-assemble into micelles (a packed chain of molecules) in aqueous solution. Micelle formation is temperature dependent and affects the degradation properties of the biomaterial: below a certain characteristic temperature, known as the critical micelle temperature, both the ethylene and propylene oxide blocks are hydrated, and the PPO block becomes soluble.
Pluronics can be found either as liquids, pastes or solids. Due to their amphiphilic characteristics (presence of hydrophobic and hydrophilic components), pluronics possess surfactant properties which allow them to interact with hydrophobic surfaces and biological membranes. Being amphiphilic also results in the ability of the individual block copolymers,
Hydrogen peroxide is seen as an environmentally safe alternative to chlorine-based bleaches, as it degrades to form oxygen and water and is generally recognized as safe as an antimicrobial agent by the U.S. Food and Drug Administration (FDA).
Historically, hydrogen peroxide was used for disinfecting wounds. Today, it is thought to inhibit healing and to induce scarring, because it destroys newly formed skin cells at high concentrations. This is understood to be caused by the drying-out effect of peroxide.
One study found that only very low concentrations (0.03%v/v solution, this is a dilution of typical 3%v/v Peroxide by 100 times) may induce healing, and only if not applied repeatedly.
A 0.5%v/v solution was found to impede healing. Recently, new studies have however shown that peroxide is an important and intrinsic part of the cellular signalling and defence system, generating a signal that activates local defence cells in response to infections and insults. In line with this it is also now known that cells employ peroxide directly to kill microbes and virus in their immediate vicinity. Because of this knowledge, peroxide has gained renewed attention as a biologically active sanitizing substance.
Pluronic acid Pluronics0 or poloxamers are tri-block copolymers of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO). This group of synthetic polymers is thermo-reversible in aqueous solutions. The sol-gel transition is governed by the composition, molecular weight and concentration of each constituent block polymer. The hydrophilic ethylene oxide and the hydrophobic propylene oxide give pluronics an amphiphilic structure ¨ meaning it has a polar, water-soluble group attached to a nonpolar water-insoluble hydrocarbon chain. Amphiphilic block copolymer molecules self-assemble into micelles (a packed chain of molecules) in aqueous solution. Micelle formation is temperature dependent and affects the degradation properties of the biomaterial: below a certain characteristic temperature, known as the critical micelle temperature, both the ethylene and propylene oxide blocks are hydrated, and the PPO block becomes soluble.
Pluronics can be found either as liquids, pastes or solids. Due to their amphiphilic characteristics (presence of hydrophobic and hydrophilic components), pluronics possess surfactant properties which allow them to interact with hydrophobic surfaces and biological membranes. Being amphiphilic also results in the ability of the individual block copolymers,
4 known as unimers, to combine and form micelles in aqueous solutions. When the concentration of the block copolymers is below that of the critical micelle concentration (CMC), the unimers remain as molecular solutions in water. However, as the block copolymer concentration is increased above the CMC, the unimers will self-assemble and form micelles, which can take on spherical, rod-shaped or lamellar geometries.
Their shapes depend on the length and concentration of the block copolymers (i.e. EO and PO), and the temperature. Micelles usually have a hydrophobic core, in this case the PO
chains, and a hydrophilic shell, the EO chains.
-: =
<
Pluronic ' 1-127 Pluronic F-127, also known as Poloxamer 407, is often used in tissue engineering because of the commercial availability of a consistent product that will undergo a sol-gel transition near physiological temperature and pH. A disadvantage of Pluronic F-127 is its fast degradation rate in vivo. To overcome this problem, Pluronic F-127 is frequently crosslinked with another a-hydroxy or amino acid in order to alter the chemical structure of its depsipeptide unit.
Pluronic acids form thermo-sensitive hydrogels, which are typically stabilized by addition of high-molecular-weight acids, such as hyaluronic acid.
Studies have documented the positive effects of pluronic acid formulations in reducing inflammation, protect tissues against damage and hinder microbial adhesion.
Furthermore, it is EMA and FDA approved, completely biocompatible and safe to use clinically with no known harmful effects in human cells.
Still, it is hard to apply as a cleaning agent because it will automatically form a stable gel at over 18 C, or even between temperatures of 12-20 C (see figure 1) dependent of its concentration, which makes it unsuitable to use in small passages and/or for use on rough surfaces or at body temperature and does not lend it to application with a syringe.
Accordingly, the need for additional cleaning and/or sterilizing and/or debriding compositions, which can be used to disinfect, sterilize or clean, prevent fouling and/or refouling of a fouled biological surface and/or a biomaterial surface, such as the mucosa of the oral or nasal cavity of a subject, or the exposed outer skin of a subject, such as hands and feet, is manifest.
Their shapes depend on the length and concentration of the block copolymers (i.e. EO and PO), and the temperature. Micelles usually have a hydrophobic core, in this case the PO
chains, and a hydrophilic shell, the EO chains.
-: =
<
Pluronic ' 1-127 Pluronic F-127, also known as Poloxamer 407, is often used in tissue engineering because of the commercial availability of a consistent product that will undergo a sol-gel transition near physiological temperature and pH. A disadvantage of Pluronic F-127 is its fast degradation rate in vivo. To overcome this problem, Pluronic F-127 is frequently crosslinked with another a-hydroxy or amino acid in order to alter the chemical structure of its depsipeptide unit.
Pluronic acids form thermo-sensitive hydrogels, which are typically stabilized by addition of high-molecular-weight acids, such as hyaluronic acid.
Studies have documented the positive effects of pluronic acid formulations in reducing inflammation, protect tissues against damage and hinder microbial adhesion.
Furthermore, it is EMA and FDA approved, completely biocompatible and safe to use clinically with no known harmful effects in human cells.
Still, it is hard to apply as a cleaning agent because it will automatically form a stable gel at over 18 C, or even between temperatures of 12-20 C (see figure 1) dependent of its concentration, which makes it unsuitable to use in small passages and/or for use on rough surfaces or at body temperature and does not lend it to application with a syringe.
Accordingly, the need for additional cleaning and/or sterilizing and/or debriding compositions, which can be used to disinfect, sterilize or clean, prevent fouling and/or refouling of a fouled biological surface and/or a biomaterial surface, such as the mucosa of the oral or nasal cavity of a subject, or the exposed outer skin of a subject, such as hands and feet, is manifest.
5 SUMMARY
Aspects of the present invention relate to an antimicrobial and/or anti-viral composition for cleaning and/or sterilizing a biological surface and/or a biomaterial surface e.g. in situ, comprising at least two components:
(a) H202 at a final concentration of between 0.1 ¨ 7%v/v, and (b) a composite hydrogel formulation of pluronic acid at a concentration of 0.1-1 0 %w/v.
The composite hydrogel formulation is typically a poloxamer. Thus, a composition of the present invention comprises an antimicrobial and/or anti viral mixture consisting of:
(a) H202 at a final concentration of between 3.0 ¨ 7.0% v/v, and (b) a poloxamer at a final concentration of 1.0%-10.0% w/v.
Typically, an antimicrobial and/or anti-viral composition as disclosed herein comprises a composite hydrogel formulation of component (b), which is a poloxamer, such as pluronic acid at a concentration of 0.1-5%w/v, such as at a concentration of at the most 5%w/v, such as at a concentration of between 1.0%-5.0% w/v, such as 0.1, 0.5, 1.0 or 1.5%w/v. The composition according to the present invention in one aspect comprises a poloxamer at a concentration of 5.0% w/v. The poloxamer can be a mixture of poloxamers.
Component (b) can be selected from the group consisting of pluronic acid, Pluronic0 F-127 and Poloxamer 407. In a presently preferred aspect, the poloxamer is Poloxamer 407.
An antimicrobial and/or anti-viral composition in some alternatives further comprises a H202 of component (a), which has a final concentration of 0.1-7%v/v, such as a final concentration of 0,5-3,0 %v/v. In one aspect, the H202 of component (a) has a final concentration of 3% v/v.
In one aspect, component (a) and component (b) are provided in a 1:1 ratio.
An antimicrobial and/or anti-viral composition in some alternatives can further comprise water and/or physiological saline, oils, preservatives flavors and/or fragrances.
In one aspect, an antimicrobial and/or anti-viral composition comprises the at least two components:
(a) H202, and (b) a composite hydrogel formulation, comprising a poloxamer, such as pluronic acid, which are kept separate from each other until they are simultaneously mixed and applied to a biological surface and/or a biomaterial surface in situ.
Aspects of the present invention relate to an antimicrobial and/or anti-viral composition for cleaning and/or sterilizing a biological surface and/or a biomaterial surface e.g. in situ, comprising at least two components:
(a) H202 at a final concentration of between 0.1 ¨ 7%v/v, and (b) a composite hydrogel formulation of pluronic acid at a concentration of 0.1-1 0 %w/v.
The composite hydrogel formulation is typically a poloxamer. Thus, a composition of the present invention comprises an antimicrobial and/or anti viral mixture consisting of:
(a) H202 at a final concentration of between 3.0 ¨ 7.0% v/v, and (b) a poloxamer at a final concentration of 1.0%-10.0% w/v.
Typically, an antimicrobial and/or anti-viral composition as disclosed herein comprises a composite hydrogel formulation of component (b), which is a poloxamer, such as pluronic acid at a concentration of 0.1-5%w/v, such as at a concentration of at the most 5%w/v, such as at a concentration of between 1.0%-5.0% w/v, such as 0.1, 0.5, 1.0 or 1.5%w/v. The composition according to the present invention in one aspect comprises a poloxamer at a concentration of 5.0% w/v. The poloxamer can be a mixture of poloxamers.
Component (b) can be selected from the group consisting of pluronic acid, Pluronic0 F-127 and Poloxamer 407. In a presently preferred aspect, the poloxamer is Poloxamer 407.
An antimicrobial and/or anti-viral composition in some alternatives further comprises a H202 of component (a), which has a final concentration of 0.1-7%v/v, such as a final concentration of 0,5-3,0 %v/v. In one aspect, the H202 of component (a) has a final concentration of 3% v/v.
In one aspect, component (a) and component (b) are provided in a 1:1 ratio.
An antimicrobial and/or anti-viral composition in some alternatives can further comprise water and/or physiological saline, oils, preservatives flavors and/or fragrances.
In one aspect, an antimicrobial and/or anti-viral composition comprises the at least two components:
(a) H202, and (b) a composite hydrogel formulation, comprising a poloxamer, such as pluronic acid, which are kept separate from each other until they are simultaneously mixed and applied to a biological surface and/or a biomaterial surface in situ.
6 According to that aspect, an antimicrobial and/or anti-viral composition comprises a separate component (a), which is a composition that comprises H202 at a concentration of at least 10-50%v/v.
A composition according to some alternatives can further comprise an additional antimicrobial substance. A composition according to some alternatives can further comprise a bioactive substance, typically selected from the group consisting of peptides, drugs, bioactive ions, small molecules, radioactive molecules, and radio-opaque molecules or any combination thereof.
A composition according to some alternatives typically has a shelf-life of at least 1 years at room temperature (RT).
A composition according to some alternatives is useful for sterilizing or sanitizing or cleaning a biological surface and/or a biomaterial surface in situ.
Typically, one or more of the compositions described herein can be used to clean, sterilize, or otherwise rid the skin and/or mucosa of a subject, preferably a human, from microbes, including but not limited to bacteria or virus, such as Riboviria, Coronaviridae, or Orthocoronavirinae.
In a presently preferred aspect, one or more of the compositions described herein are used to clean or sterilize skin and/or mucosa from a Coronavirus, such as SARS-CoV-2.
In consequence, aspects of the present invention relate to the application of one or more of the antimicrobial and/or anti-viral compositions described herein as a hand wash, oral wash and/or for nasal and/or sinus cleansing, so as to remove, sterilize, or inhibit a Coronavirus, such as SARS-CoV-2 from the skin or mucosa of a subject, preferably a human.
Aspects of the present invention also concern the use of one or more of the compositions described herein for cleaning and/or sanitizing a biological surface and/or a biomaterial surface, such as in particular an implant in situ and/or a surface in the oral cavity and/or any surface covered by skin or mucosa.
In some alternatives, one or more of the compositions described herein are incorporated in a kit, wherein the at least two components, H202 and pluronic acid, are optionally kept separate such that a user may mix the two components just prior to application.
The invention consequently also relates to a method of sanitizing, sterilizing, disinfecting and/or decontaminating a biological surface and/or a biomaterial surface comprising applying the composition according to the present invention to a biological surface and/or a biomaterial surface, as well as a method of cleaning skin and/or mucosa of a subject from
A composition according to some alternatives can further comprise an additional antimicrobial substance. A composition according to some alternatives can further comprise a bioactive substance, typically selected from the group consisting of peptides, drugs, bioactive ions, small molecules, radioactive molecules, and radio-opaque molecules or any combination thereof.
A composition according to some alternatives typically has a shelf-life of at least 1 years at room temperature (RT).
A composition according to some alternatives is useful for sterilizing or sanitizing or cleaning a biological surface and/or a biomaterial surface in situ.
Typically, one or more of the compositions described herein can be used to clean, sterilize, or otherwise rid the skin and/or mucosa of a subject, preferably a human, from microbes, including but not limited to bacteria or virus, such as Riboviria, Coronaviridae, or Orthocoronavirinae.
In a presently preferred aspect, one or more of the compositions described herein are used to clean or sterilize skin and/or mucosa from a Coronavirus, such as SARS-CoV-2.
In consequence, aspects of the present invention relate to the application of one or more of the antimicrobial and/or anti-viral compositions described herein as a hand wash, oral wash and/or for nasal and/or sinus cleansing, so as to remove, sterilize, or inhibit a Coronavirus, such as SARS-CoV-2 from the skin or mucosa of a subject, preferably a human.
Aspects of the present invention also concern the use of one or more of the compositions described herein for cleaning and/or sanitizing a biological surface and/or a biomaterial surface, such as in particular an implant in situ and/or a surface in the oral cavity and/or any surface covered by skin or mucosa.
In some alternatives, one or more of the compositions described herein are incorporated in a kit, wherein the at least two components, H202 and pluronic acid, are optionally kept separate such that a user may mix the two components just prior to application.
The invention consequently also relates to a method of sanitizing, sterilizing, disinfecting and/or decontaminating a biological surface and/or a biomaterial surface comprising applying the composition according to the present invention to a biological surface and/or a biomaterial surface, as well as a method of cleaning skin and/or mucosa of a subject from
7 microbes comprising applying the composition according to the present invention to the skin and/or mucosa of a subject. The microbes comprise bacteria or virus or both, such as, but not limited to Riboviria, Coronaviridae, Orthomyxoviridae, Caliciviridae or Reoviridae or any combination thereof. The microbes comprise Orthocoronavirinae, such as, but not limitted to Coronavirus, Rota virus, Noro virus or Influenza virus type A, B, C or D or any combination thereof.
DEFINITIONS and ABBREVIATIONS
Aspects of the present invention provides compositions and methods to clean and/or sanitize a biological surface and/or a biomaterial, such as an implant surface.
In the present context, a biological surface refers to any surface covering an anatomical structure and/or tissue, such as skin including palmar and plantar skin, oral and nasal mucosa, gastrointestinal mucosa, laryngeal, tracheal and bronchial mucosa, vaginal mucosa, penile mucosa, hair, nails, fasciae, membranes, synovial membranes, dental enamel or dental cementum. The term also encompasses a wound surface, such as in, on and/or surrounding, but not limited to, an ulcer, acute wound, wound from trauma, surgical wound, puncture wound, abrasive wound, infected wound including herpes ulcer, papilloma, chancre and acne, erosive wound, burn, blister, scab, leg ulcer, diabetic ulcer and/or chronic ulcer.
In the present context, the term "biomaterial or implant surface" typically refers to a surface of a medical and/or dental implant.
In the present context, the term "medical implant" includes within its scope any device intended to be implanted into and/or attached to the body of a vertebrate animal, in particular a mammal such as a human, for preservation and restoration of the function of the body, particularly a prosthesis of any kind, metallic and polymer-based implants in the vascular system or in the musculoskeletal system or in joints and bones, including for alleviation of pain in these structures. Non-limiting examples of medical implants are leg, arm and hand prosthesis, facial prosthesis, eye prosthesis, ileostomy devices, intrauterine devices, pacemakers, electrodes, artificial vascular structures, stents, cochlear implants, hip-joint prostheses, knee prostheses, elbow prostheses, finger prostheses, cochlear prostheses, or fixation screws.
In the present context, the term "dental implant" includes within its scope any device intended to be implanted into the oral cavity of a vertebrate animal, in particular a mammal
DEFINITIONS and ABBREVIATIONS
Aspects of the present invention provides compositions and methods to clean and/or sanitize a biological surface and/or a biomaterial, such as an implant surface.
In the present context, a biological surface refers to any surface covering an anatomical structure and/or tissue, such as skin including palmar and plantar skin, oral and nasal mucosa, gastrointestinal mucosa, laryngeal, tracheal and bronchial mucosa, vaginal mucosa, penile mucosa, hair, nails, fasciae, membranes, synovial membranes, dental enamel or dental cementum. The term also encompasses a wound surface, such as in, on and/or surrounding, but not limited to, an ulcer, acute wound, wound from trauma, surgical wound, puncture wound, abrasive wound, infected wound including herpes ulcer, papilloma, chancre and acne, erosive wound, burn, blister, scab, leg ulcer, diabetic ulcer and/or chronic ulcer.
In the present context, the term "biomaterial or implant surface" typically refers to a surface of a medical and/or dental implant.
In the present context, the term "medical implant" includes within its scope any device intended to be implanted into and/or attached to the body of a vertebrate animal, in particular a mammal such as a human, for preservation and restoration of the function of the body, particularly a prosthesis of any kind, metallic and polymer-based implants in the vascular system or in the musculoskeletal system or in joints and bones, including for alleviation of pain in these structures. Non-limiting examples of medical implants are leg, arm and hand prosthesis, facial prosthesis, eye prosthesis, ileostomy devices, intrauterine devices, pacemakers, electrodes, artificial vascular structures, stents, cochlear implants, hip-joint prostheses, knee prostheses, elbow prostheses, finger prostheses, cochlear prostheses, or fixation screws.
In the present context, the term "dental implant" includes within its scope any device intended to be implanted into the oral cavity of a vertebrate animal, in particular a mammal
8 such as a human, for example in tooth and jaw restoration procedures. Dental implants are herein selected from the group consisting of: Implants, bars, bridges, abutments, crowns, caps, dental fillings and prosthetic parts in the oral cavity. Dental implants may also be denoted as dental prosthetic devices. Generally, a dental implant is composed of one or several implant parts. For instance, a dental implant usually comprises a dental fixture coupled to secondary implant parts, such as an abutment and/or a dental restoration such as a crown, bridge or denture. However, any device, such as a dental fixture, intended for implantation may alone be referred to as an implant even if other parts are to be connected thereto.
In a second embodiment, the term biomaterial surface includes the surface of any medical device or tool, disposable or not, designed to come in temporary contact with living tissue, such as, but not limited to, surgical instruments, electrodes, scalpels, probes and gauges, catheters, syringes, scissors, needle holders, contact lenses, wound dressings, band aids, transdermal fixing devices, and/or diagnostic tools like ultrasound devices, x-ray machines and/or imaging equipment, e.g. various scopes, surgical cameras, impression materials or intraoral scanners.
In the present context, the term peroxide is used interchangeably with Hydrogen peroxide and/or (H202).
A microorganism, or microbe, is a microscopic organism, which may exist in its single-celled form or in a colony of cells. Microorganisms include all unicellular organisms and so are extremely diverse. All of the Archaea and Bacteria are microorganisms (Prokaryotes). Some protists are related to animals and some to green plants. Many of the multicellular organisms are microscopic, namely micro-animals, some fungi and some algae.
An antimicrobial is an agent that kills microorganisms or stops or inhibits their growth.
Antimicrobial medicines can be grouped according to the microorganisms they act primarily against. For example, antibiotics are used to treat or inhibit bacteria, and antifungals are used to treat or inhibit fungi. They can also be classified according to their function. Agents that kill microbes are microbicidal, while those that merely inhibit their growth are called biostatic both are included in the term" antimicrobial". The use of antimicrobial medicines to treat or inhibit infection is known as antimicrobial chemotherapy, while the use of antimicrobial medicines to prevent infection is known as antimicrobial prophylaxis.
In a second embodiment, the term biomaterial surface includes the surface of any medical device or tool, disposable or not, designed to come in temporary contact with living tissue, such as, but not limited to, surgical instruments, electrodes, scalpels, probes and gauges, catheters, syringes, scissors, needle holders, contact lenses, wound dressings, band aids, transdermal fixing devices, and/or diagnostic tools like ultrasound devices, x-ray machines and/or imaging equipment, e.g. various scopes, surgical cameras, impression materials or intraoral scanners.
In the present context, the term peroxide is used interchangeably with Hydrogen peroxide and/or (H202).
A microorganism, or microbe, is a microscopic organism, which may exist in its single-celled form or in a colony of cells. Microorganisms include all unicellular organisms and so are extremely diverse. All of the Archaea and Bacteria are microorganisms (Prokaryotes). Some protists are related to animals and some to green plants. Many of the multicellular organisms are microscopic, namely micro-animals, some fungi and some algae.
An antimicrobial is an agent that kills microorganisms or stops or inhibits their growth.
Antimicrobial medicines can be grouped according to the microorganisms they act primarily against. For example, antibiotics are used to treat or inhibit bacteria, and antifungals are used to treat or inhibit fungi. They can also be classified according to their function. Agents that kill microbes are microbicidal, while those that merely inhibit their growth are called biostatic both are included in the term" antimicrobial". The use of antimicrobial medicines to treat or inhibit infection is known as antimicrobial chemotherapy, while the use of antimicrobial medicines to prevent infection is known as antimicrobial prophylaxis.
9 A virus is a small infectious agent that replicates only inside the living cells of an organism.
Viruses can infect all types of life forms, from animals and plants to microorganisms, including bacteria and archaea.
Antiviral drugs are a class of medication used specifically for treating or inhibiting viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses.
Unlike most antibiotics, most antiviral drugs do not destroy their target pathogen;
instead they inhibit their replication and/or development.
Antiviral drugs are one class of antimicrobials, a larger group which also includes antibiotic (also termed antibacterial), antifungal and antiparasitic drugs, or antiviral drugs based on monoclonal antibodies. Most antivirals are considered relatively harmless to the host, and therefore can be used to treat or inhibit infections. They should be distinguished from viricides, which are not medication but deactivate or destroy virus particles, either inside or outside the body. Natural antivirals are produced by some plants such as eucalyptus or Australian tea trees.
As used in the present context, the term "antimicrobial", refers to a composition that is effective against microbes and virus. In its broadest meaning, one or more of the compositions described herein are antimicrobial, e.g., antibacterial or antiviral, a bactericide or a viricide.
As used herein, the term "about" or "approximately" means within an acceptable error range for the particular value as determined by one of ordinary skill in the art, which will depend in part on how the value is measured or determined e.g., the limitations of the measurement system.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1: Gel boundaries for aqueous saline (physiological conditions) solutions of copolymer F-127. The filled circles are data points obtained by the tube inversion method for the mixture. The unfilled squares are data points from rheometric analyses. The chart clearly indicates that pluronic concentrations below 15% w/v in saline remains fluid independent of temperature. Fluid pluronic solutions form independent micelles, but the concentration is not high enough for the pluronic micelles to assemble into a cubic gel. Thus, low pluronic concentrations that allow for micelle formation but stay liquid and act as detergent may be good for tissue-friendly cleaning of biological surfaces, but addition of other reactants that can contribute to the decontamination is 5 expected to completely disrupt the micelle formation.
Figure 2: Schematic drawing depicting the synergistic effects from mixing pluronic with peroxide. During the interaction with pluronic, the peroxide generates active oxygen (ROS) degrade microbial and viral nucleic acids and membranes, and
Viruses can infect all types of life forms, from animals and plants to microorganisms, including bacteria and archaea.
Antiviral drugs are a class of medication used specifically for treating or inhibiting viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses.
Unlike most antibiotics, most antiviral drugs do not destroy their target pathogen;
instead they inhibit their replication and/or development.
Antiviral drugs are one class of antimicrobials, a larger group which also includes antibiotic (also termed antibacterial), antifungal and antiparasitic drugs, or antiviral drugs based on monoclonal antibodies. Most antivirals are considered relatively harmless to the host, and therefore can be used to treat or inhibit infections. They should be distinguished from viricides, which are not medication but deactivate or destroy virus particles, either inside or outside the body. Natural antivirals are produced by some plants such as eucalyptus or Australian tea trees.
As used in the present context, the term "antimicrobial", refers to a composition that is effective against microbes and virus. In its broadest meaning, one or more of the compositions described herein are antimicrobial, e.g., antibacterial or antiviral, a bactericide or a viricide.
As used herein, the term "about" or "approximately" means within an acceptable error range for the particular value as determined by one of ordinary skill in the art, which will depend in part on how the value is measured or determined e.g., the limitations of the measurement system.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1: Gel boundaries for aqueous saline (physiological conditions) solutions of copolymer F-127. The filled circles are data points obtained by the tube inversion method for the mixture. The unfilled squares are data points from rheometric analyses. The chart clearly indicates that pluronic concentrations below 15% w/v in saline remains fluid independent of temperature. Fluid pluronic solutions form independent micelles, but the concentration is not high enough for the pluronic micelles to assemble into a cubic gel. Thus, low pluronic concentrations that allow for micelle formation but stay liquid and act as detergent may be good for tissue-friendly cleaning of biological surfaces, but addition of other reactants that can contribute to the decontamination is 5 expected to completely disrupt the micelle formation.
Figure 2: Schematic drawing depicting the synergistic effects from mixing pluronic with peroxide. During the interaction with pluronic, the peroxide generates active oxygen (ROS) degrade microbial and viral nucleic acids and membranes, and
10 kills bacteria, including anaerobes, and viruses. The peroxide also drives pluronic micelle dissolution that is countered by the strong tendency of pluronic to form micelle structures. The dynamic equilibrium between solubilized and micelle pluronic allow for an active entrapment of dirt, organics and contaminants into the micelle structure. The liquid hydrophilic nature of the pluronic hydrogel also promotes easy access for the ROS to wrinkles and crevices, unhindered by foaming. Moreover, the pluronic hydrogel moisture the skin and the oxygen released from the peroxide helps the wound to heal. The ROS also has the ability to clean and reactivate (make the surface hydrophilic) titanium, one of the most widely used metal in medical and dental implants.
The effect of ROS alone is too brief to have a significant impact on these processes and would not remove the contaminants or provide moisture. Pluronic alone for stable micelles that is far less effective in contaminant entrapment and do not kill microbes or degrade viral nucleic acids. Mixed together in the right concentration pluronic micelle formation is more dynamic, moistening and oxygenation is optimized, and the peroxide action is prolonged and increased and kept at the surface where it is needed.
Figure 3: Titanium surfaces contaminated with S. Epidermidis bacteria was cleaned with growth medium (BHI, Negative control), H202 5% v/v + f-127 1% w/v (Test 2), H202 5% v/v + f-127 7% w/v (Test 4), Chlorhexidine 0,2% w/v + f-127 7% w/v (Test 5) or Ethanol 75% v/v + f-127 1% w/v. The negative control did not remove the bacteria, nor was the bacteria destroyed. The peroxide + pluronic acid mix killed all bacteria, dissolved the biofilm and removed the debris almost completely (Tests 2 & 4). Test 4 was slightly, but not statistically significant, more effective than Test 2. Chlorhexidine (Test 5) and Ethanol (Test 6) did kill most of the bacteria but did not remove any debris from the surface, leaving
The effect of ROS alone is too brief to have a significant impact on these processes and would not remove the contaminants or provide moisture. Pluronic alone for stable micelles that is far less effective in contaminant entrapment and do not kill microbes or degrade viral nucleic acids. Mixed together in the right concentration pluronic micelle formation is more dynamic, moistening and oxygenation is optimized, and the peroxide action is prolonged and increased and kept at the surface where it is needed.
Figure 3: Titanium surfaces contaminated with S. Epidermidis bacteria was cleaned with growth medium (BHI, Negative control), H202 5% v/v + f-127 1% w/v (Test 2), H202 5% v/v + f-127 7% w/v (Test 4), Chlorhexidine 0,2% w/v + f-127 7% w/v (Test 5) or Ethanol 75% v/v + f-127 1% w/v. The negative control did not remove the bacteria, nor was the bacteria destroyed. The peroxide + pluronic acid mix killed all bacteria, dissolved the biofilm and removed the debris almost completely (Tests 2 & 4). Test 4 was slightly, but not statistically significant, more effective than Test 2. Chlorhexidine (Test 5) and Ethanol (Test 6) did kill most of the bacteria but did not remove any debris from the surface, leaving
11 the surfaces heavily contaminated. Surfaces visualized after cleaning in a scanning electron microscope. Scale bar is 20 micrometres.
Figure 4: Titanium surfaces contaminated with S. Epidermidis bacteria was cleaned with A) saline (Negative control), B) Chlorhexidine 0,2% w/v, or C) H202 3% v/v +
f-127 pluronic Acid 5% w/v. After cleaning the surfaces were stained with fluorescent dyes, green for living cells and red for dead cells. The negative control (saline) did not remove any of the bacteria, nor was the bacteria destroyed. The chlorhexidine killed all bacteria but left them to contaminate the surface. The hydrogen peroxide + pluronic acid mix killed all bacteria, dissolved the biofilm and removed the debris almost completely Surfaces visualized in a confocal microscope after cleaning and staining.
Figure 5: Regrowth of S. Epidermidis bacteria, harbouring the luciferase gene making them fluorescent, on sanitized titanium surfaces. The results show that D) water with detergent (SDS, 0,1%), E) water with 5% pluronic acid and F) saline had minimal sanitizing effect, as regrowth of the biofilm occurred within 3-4 hours after cleaning. Chlorhexidine, 0,2%, on the other hand killed all bacteria with no regrowth observed although the dead biofilm stuck and remained on the surface (see figure 3 and 4). Hydrogen peroxide, 5% v/v, alone (A) cleaned the surface well as seen by a delay of about 13 hours before the biofilm restored itself. However, hydrogen peroxide 3% v/v combined with 5% pluronic acid in water cleaned the surface significantly better, delaying regrowth with more than 15 hours.
Figure 6: Left and right thumbs were sanitized four times daily for five consecutive days with a mix of A) pluronic acid (5% w/v) and hydrogen peroxide (3% v/v) or B) Antibac PharmaTM containing ethanol and propan-2-ol respectively. After the sanitizing period both fingers were stained with iron oxide to visualize fissures and cracks. Fissures and cracks are easily visible as brown striated stains on the Antibac PharmaTM treated thumb, whereas the pluronic-peroxide formulation caused no harm to the skin of the left finger.
Figure 4: Titanium surfaces contaminated with S. Epidermidis bacteria was cleaned with A) saline (Negative control), B) Chlorhexidine 0,2% w/v, or C) H202 3% v/v +
f-127 pluronic Acid 5% w/v. After cleaning the surfaces were stained with fluorescent dyes, green for living cells and red for dead cells. The negative control (saline) did not remove any of the bacteria, nor was the bacteria destroyed. The chlorhexidine killed all bacteria but left them to contaminate the surface. The hydrogen peroxide + pluronic acid mix killed all bacteria, dissolved the biofilm and removed the debris almost completely Surfaces visualized in a confocal microscope after cleaning and staining.
Figure 5: Regrowth of S. Epidermidis bacteria, harbouring the luciferase gene making them fluorescent, on sanitized titanium surfaces. The results show that D) water with detergent (SDS, 0,1%), E) water with 5% pluronic acid and F) saline had minimal sanitizing effect, as regrowth of the biofilm occurred within 3-4 hours after cleaning. Chlorhexidine, 0,2%, on the other hand killed all bacteria with no regrowth observed although the dead biofilm stuck and remained on the surface (see figure 3 and 4). Hydrogen peroxide, 5% v/v, alone (A) cleaned the surface well as seen by a delay of about 13 hours before the biofilm restored itself. However, hydrogen peroxide 3% v/v combined with 5% pluronic acid in water cleaned the surface significantly better, delaying regrowth with more than 15 hours.
Figure 6: Left and right thumbs were sanitized four times daily for five consecutive days with a mix of A) pluronic acid (5% w/v) and hydrogen peroxide (3% v/v) or B) Antibac PharmaTM containing ethanol and propan-2-ol respectively. After the sanitizing period both fingers were stained with iron oxide to visualize fissures and cracks. Fissures and cracks are easily visible as brown striated stains on the Antibac PharmaTM treated thumb, whereas the pluronic-peroxide formulation caused no harm to the skin of the left finger.
12 Figure 7: Fingers were marked with a line of permanent ink from a laboratory marker that was subsequently washed off with various sanitizing/decontaminating solutions to visualize their ability to remove contaminants from the skin. Finger A) was washed only with water. Finger B) was cleaned with warm water and soap.
Finger C) was cleaned with 0,2% chlorhexidine and finger D) was rinsed with PyrispetTM (0,1% cetyl-pyridinium chloride). Finger E) was cleaned with Antibac PharmaTM (Alcohol based sanitizer), finger F) was cleaned with bleach (4%
Sodium hypochlorite). Fingers G) and H) were rinsed with hydrogen peroxide (1% and 5% v/v in water respectively). Finger I) was washed in a solution of pluronic acid in water (5% w/v). Finger J) was sanitized with a mix of pluronic acid (5% w/v) and hydrogen peroxide (1% v/v). The results show that bleach and hydrogen peroxide is effective in removing the ink stain, but that the most efficient cleaning is obtained by the combination of pluronic acid and hydrogen peroxide.
DETAILED DESCRIPTION
There has been a long felt need in community for the presently described compositions, which effectively clean, disinfect and/or sanitize a biological surface and/or a biomaterial surface. e.g., including but not limited to skin or mucosa, such as a surface in the oro-laryngeal or nasal cavity. Any one or more of the compositions described herein are useful for the rapid and effective treatment or inhibition of bacteria or virus or both essentially without leaving contaminating material residues.
The presently described compositions are water soluble and easy to rinse off, tissue-friendly non-ionic surfactant. These compositions comprise a non-toxic formulation of well-studied active ingredients in clinical use, which is particularly suitable for injectable, oral and/or cutaneous applications. The herein for the first time described composition is proven to be non-sensitizing and non-irritating in clinical tests. The compositions described herein are compatible with most other therapeutic agents useful against biofouling and inflammation.
The compositions described herein have a liquid state at room temperature that allows trouble-free mixing and application. The compositions have an easy flowing liquid consistency with a surfactant effect that allows the compositions to reach difficult places when applied into narrow crevices, defects and/or folds on skin and/or mucosa.
Without being bound to a particular theory or mechanism of action, it is contemplated that he compositions described herein mimic the natural release of reactive oxygen species (ROS) from peroxide produced by human cells. The charge from the reactive oxygen destroys
Finger C) was cleaned with 0,2% chlorhexidine and finger D) was rinsed with PyrispetTM (0,1% cetyl-pyridinium chloride). Finger E) was cleaned with Antibac PharmaTM (Alcohol based sanitizer), finger F) was cleaned with bleach (4%
Sodium hypochlorite). Fingers G) and H) were rinsed with hydrogen peroxide (1% and 5% v/v in water respectively). Finger I) was washed in a solution of pluronic acid in water (5% w/v). Finger J) was sanitized with a mix of pluronic acid (5% w/v) and hydrogen peroxide (1% v/v). The results show that bleach and hydrogen peroxide is effective in removing the ink stain, but that the most efficient cleaning is obtained by the combination of pluronic acid and hydrogen peroxide.
DETAILED DESCRIPTION
There has been a long felt need in community for the presently described compositions, which effectively clean, disinfect and/or sanitize a biological surface and/or a biomaterial surface. e.g., including but not limited to skin or mucosa, such as a surface in the oro-laryngeal or nasal cavity. Any one or more of the compositions described herein are useful for the rapid and effective treatment or inhibition of bacteria or virus or both essentially without leaving contaminating material residues.
The presently described compositions are water soluble and easy to rinse off, tissue-friendly non-ionic surfactant. These compositions comprise a non-toxic formulation of well-studied active ingredients in clinical use, which is particularly suitable for injectable, oral and/or cutaneous applications. The herein for the first time described composition is proven to be non-sensitizing and non-irritating in clinical tests. The compositions described herein are compatible with most other therapeutic agents useful against biofouling and inflammation.
The compositions described herein have a liquid state at room temperature that allows trouble-free mixing and application. The compositions have an easy flowing liquid consistency with a surfactant effect that allows the compositions to reach difficult places when applied into narrow crevices, defects and/or folds on skin and/or mucosa.
Without being bound to a particular theory or mechanism of action, it is contemplated that he compositions described herein mimic the natural release of reactive oxygen species (ROS) from peroxide produced by human cells. The charge from the reactive oxygen destroys
13 microbial membranes and the oxygen itself is also toxic to anaerobic bacteria.
The human cells themselves are protected against ROS by enzymes in their cell membrane and the local tissue can benefit from the increase in oxygen. Microbes have no such protection, nor can they develop resistance because of fundamental differences in their cell-membrane design. Thus, the composition can effectively dissolve biofilm, debris and mineral deposits, as well as, dissolve extracellular organics at the application site.
Through the active oxygen released from the liquid hydrogel, the use of the herein presented compositions also remove carbon contamination from a titanium containing implant surface and reactivate the titanium dioxide layer of the implant. This process re-establishes the original charge and hydrophilicity of the implant, restoring its optimal biological surface properties. This is a factor for further survival, or even successful reintegration, of said treated implant. The present compositions provide an advanced micelle forming gel formulation that works in synergy with natural occurring oxygen to break down and remove biofouling, eliminate microbes, keep tissue and implant moist and reactivate titanium implant surfaces.
The hydrogel component of the compositions and the active oxygen work in synergy to avoid foaming from oxygen release and to keep activated oxygen in place at the surface for a prolonged biological and chemical effect. The use of any one or more of the compositions set forth herein provides moisture and allows the charged oxygen to work without risk of drying out skin, tissue and/or implant surfaces, during which the active oxygen eradicates microbes that are then suspended and entrapped inside the micelle-forming hydrogel.
Organic contaminants are in turn denatured by the strong detergent effect, broken down by the active oxygen and dissolved and entrapped in the hydrogel. Both hydrogel and oxygen reduce inflammation and support tissue health. The active oxygen released in turn strengthens the cellular defence network. In synergy, the gel and the active oxygen both removes contaminants, acts as an antimicrobial and viricidal agent and reactivates a titanium implant surface. The interaction between the pluronic micelle formation and peroxide potentiates micelle formation and increases the cleaning effect significantly.
The presently described compositions provide a novel formula of a biocompatible hydrogel-peroxide combination with strong, antimicrobial, viricidal and non-ionic detergent properties with improved micelle dynamics for solubilization and entrapment of debris and microbes for effectively cleaning, sanitizing, sterilizing and/or debriding a biological surface and/or a biomaterial surface in situ. It is easily rinsed off with a towel, wipe or by water, but it can also be left to air-dry and will completely decompose to water, oxygen and carbon dioxide.
The presently disclosed compositions provide a novel and improved approach to cleaning, sanitizing, sterilizing and/or disinfecting skin, mucosa and/or implant surfaces. In particular alternatives, for example, any one or more of the compositions described herein are incorporated into a mouth wash and/or nasal rinse and these formulations can be used to
The human cells themselves are protected against ROS by enzymes in their cell membrane and the local tissue can benefit from the increase in oxygen. Microbes have no such protection, nor can they develop resistance because of fundamental differences in their cell-membrane design. Thus, the composition can effectively dissolve biofilm, debris and mineral deposits, as well as, dissolve extracellular organics at the application site.
Through the active oxygen released from the liquid hydrogel, the use of the herein presented compositions also remove carbon contamination from a titanium containing implant surface and reactivate the titanium dioxide layer of the implant. This process re-establishes the original charge and hydrophilicity of the implant, restoring its optimal biological surface properties. This is a factor for further survival, or even successful reintegration, of said treated implant. The present compositions provide an advanced micelle forming gel formulation that works in synergy with natural occurring oxygen to break down and remove biofouling, eliminate microbes, keep tissue and implant moist and reactivate titanium implant surfaces.
The hydrogel component of the compositions and the active oxygen work in synergy to avoid foaming from oxygen release and to keep activated oxygen in place at the surface for a prolonged biological and chemical effect. The use of any one or more of the compositions set forth herein provides moisture and allows the charged oxygen to work without risk of drying out skin, tissue and/or implant surfaces, during which the active oxygen eradicates microbes that are then suspended and entrapped inside the micelle-forming hydrogel.
Organic contaminants are in turn denatured by the strong detergent effect, broken down by the active oxygen and dissolved and entrapped in the hydrogel. Both hydrogel and oxygen reduce inflammation and support tissue health. The active oxygen released in turn strengthens the cellular defence network. In synergy, the gel and the active oxygen both removes contaminants, acts as an antimicrobial and viricidal agent and reactivates a titanium implant surface. The interaction between the pluronic micelle formation and peroxide potentiates micelle formation and increases the cleaning effect significantly.
The presently described compositions provide a novel formula of a biocompatible hydrogel-peroxide combination with strong, antimicrobial, viricidal and non-ionic detergent properties with improved micelle dynamics for solubilization and entrapment of debris and microbes for effectively cleaning, sanitizing, sterilizing and/or debriding a biological surface and/or a biomaterial surface in situ. It is easily rinsed off with a towel, wipe or by water, but it can also be left to air-dry and will completely decompose to water, oxygen and carbon dioxide.
The presently disclosed compositions provide a novel and improved approach to cleaning, sanitizing, sterilizing and/or disinfecting skin, mucosa and/or implant surfaces. In particular alternatives, for example, any one or more of the compositions described herein are incorporated into a mouth wash and/or nasal rinse and these formulations can be used to
14 prevent, treat, inhibit, or ameliorate, an oral and/ or nasal disease (e.g., dental caries, periodontitis, gingivitis, mucositis, peri-implantitis, sinusitis and/or rhinitis). In additional alternatives, said mouth rinses and/or nasal rinses can be used in methods to inhibit bacterial or viral infections, such as SARS-CoV-2 in the oral or nasal mucosa of a subject, such as a human.
The desired formulations set forth herein are based on the combination of hydrogen peroxide (H202) and pluronic acid in such a concentration that the resulting composition is in a watery liquid form at physiological temperatures. The H202 component of the composition can either be in the form of a concentrate (at a concentration of at least 10-50%v/v.) in a separate vial for mixing immediately before use, or provided as an emulsion or dissolved directly into a hydrogel, said hydrogel at least partly consisting of pluronic acid and water and/or physiological saline, with a typical final concentration of 0.5 ¨ 7%.
The pluronic component itself can be any one or a combination of the pluronic acids, e.g.
the F-127 variety. The concentration of pluronic acid is typically 0.1-10% w/v, such as 0.1-7% w/v, such as 0.1-2.5% w/v. That is, the concentration of pluronic acid in any one or more of the compositions described herein can be at least or equal to 0.1%, 0.5%, 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%, 4.5%, 5.0%, 5.5%, 6.0%, 6.5%, 7.0%, 7.5%, 8.0%, 8.5%, 9.0%, or 10% w/v or a percentage w/v that is within a range defined by any two of the aforementioned percentages.
Pluronic-acid works both as solubilizer and detergent in the composition disclosed herein, as well as a moisturizer. In the presence of peroxide, the hydrogel formulation establishes a dynamic micelle forming solution. This dynamic state facilitates efficient solubilization and entrapment of particles, microbes and pollutants during the cleaning procedure (see e.g.
Figure 2).
The present innovation is based on a synergetic effect between pluronic acid and peroxide.
Pluronic acid has an ability to form micelles. This ability usually increases with increasing temperature and is shifted toward a gel state at physiological conditions (such as at >20 degrees Celsius). The peroxide addition allows the pluronic acid to stay in the liquid state even at physiological temperature.
When mixed with hydrogen peroxide, the present inventors for the first time disclose that the micelles are more dynamic and less stable and in a "dynamic" equilibrium with the peroxide radical activity even under high temperature. In effect, this means that in the presence of peroxide, the micelle structure is dissolved and reforms constantly also when the gel is applied onto human tissue, skin and/or mucosa. This effect keeps the hydrogel liquid also at high temperatures and increases the detergent, denaturation and entrapment effect of the pluronic acid significantly.
Combined with the effect of hydrogen peroxide to release free oxygen radicals on viral particles, microbes and necrotic tissue, the micelle transitions dissolve and entrap organic contamination that are then removed when the gel dries off, is wiped off, or washed off.
5 Desirably, the addition of hydrogen peroxide to the pluronic acid in the compositions described herein increases the temperature at when gelation occurs. e.g., that the pluronic gel, containing low concentrations of peroxide, is liquid at room temperate and thus can be applied through a syringe needle or from a dispenser bottle without clogging the nozzle. This is not possible with pluronic acid alone because it starts forming a stable "packed micelle"
10 gel already at room temperature, even at low concentrations when in narrow compartments and/or at the "vapor front" at the nozzle of the dispenserõ thus is very hard to squeeze through a narrow tip of a syringe, or a pump applicator from a dispenser bottle. pluronic gel for wound care is therefore sold as gel in a box or a tube. The increased effect from the combination of peroxide and pluronic acid was unexpected and surprising.
The liquid formulation of the pluronic hydrogel in combination with peroxide also assists during application. It enables the cleaning and/or sanitizing composition to reach folds, wrinkles, crevices, fissures, narrow spaces and/or undercuts that a pluronic gel alone cannot reach because of its gel forming nature making it viscous at physiological temperatures.
Thus, it is more efficient in cleaning rough (implant) surfaces, narrow spaces such as folds, fissures and wrinkles on skin and mucosa and between teeth.
Compositions Aspects of the present invention relate to novel antimicrobial and/or anti-viral compositions, which can be used for cleaning, sanitizing, sterilizing, disinfecting and/or decontaminating a biological surface and/or a biomaterial surface in situ. In some alternatives, the aforementioned compositions comprise two components:
a. H202 at a final concentration of between 0.1 - 7%v/v, and b. a composite hydrogel formulation of pluronic acid at a concentration of 0.1 - 10%w/v.
In some of the aforementioned compositions, the final concentration of H202 is at least or equal to 0.1%, 0.5%, 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%, 4.5%, 5.0%, 5.5%, 6.0%, 6.5%, or 7.0% w/v or a percentage w/v that is within a range defined by any two of the aforementioned percentages. In some of the aforementioned compositions, the final concentration of pluronic acid is at least or equal to 0.1%, 0.5%, 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%, 4.5%, 5.0%, 5.5%, 6.0%, 6.5%, 7.0%, 7.5%, 8.0%, 8.5%, 9.0%, or 10%
w/v or a percentage w/v that is within a range defined by any two of the aforementioned percentages.
Preferably, said compositions are formulated so that they remain a liquid at physiological temperatures, such as at a temperature of at the most 40 C, such as at a temperature between 20-40 C, such as at 37 C e.g., 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, or 40 C or at a temperature that is within a range defined by any two of the aforementioned temperatures.
Some of the presently disclosed compositions are characterized in that they comprise a low concentration of pluronic acid, which allows the composition to be in a liquid state in high temperature instead of in a gel-state, which a desirable feature for it to be usable for cleaning, sanitizing, sterilizing, disinfecting and/or decontaminating a biological surface and/or a biomaterial surface in situ. In particular, the liquid state of the hydrogel is desired when the composition is incorporated into a hand sanitizer, hand wash, oral wash and/or for nasal and/or sinus cleansing solution, in particular for washing virus off of skin and mucosa.
The presently disclosed compositions comprise the at least two components (a) and (b) in such a ratio that the composition is in a liquid state at physiological temperatures instead of in a more viscous or gel-like state. Typical ratios of concentrations between component (a) and component (b) are approximately 1:1 (concentration of H202: concentration of pluronic acid). In general, the higher the concentration of the pluronic acid, the higher the concentration of the H202 is needed to keep the composition in a liquid state at temperatures of between 25-40 C. However, too high concentrations of peroxide will destroy the pluronic acid amphiphilic properties and disrupt micelle formation, rendering it useless as a detergent and/or a desatu rating agent.
In one alternative of an antimicrobial and/or anti-viral composition according to the present invention, the composite hydrogel formulation of component (b) comprises pluronic acid at a concentration of 0.1-10%w/v, such as at a concentration of 10% w/v, such as of 0.1, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9 or 9.5 %w/v or an amount that is within a range defined by any two of the aforementioned concentrations.
In another alternative of an antimicrobial and/or anti-viral composition according to the present invention, the composite hydrogel formulation of component (b) comprises pluronic acid at a concentration of at the most 10% w/v, such as at the most 0.1, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9 or 9.5 %w/v or an amount that is within a range defined by any two of the aforementioned concentrations.
An antimicrobial and/or anti-viral composition according to the present invention can be a composition wherein the H202 of component (a) has a final concentration of 0.1-7%v/v, such as 0.5-3%v/v, such as 0.1-5 /0v/v. In one embodiment, the H202 of component (a) has a final concentration of no more than 7%v/v, such as 0.1-7`)/ov/v, such as 1, 2, 3, 4, 5, 6 or 7%v/v.
An antimicrobial and/or anti-viral composition according to the present invention can further comprise water and/or physiological saline.
The two components of the antimicrobial and/or anti-viral composition according to the present invention can be in one solution or the at least two components can be kept separate from each other such that they can be simultaneously mixed and applied to a biological surface and/or a biomaterial surface in situ.
In an antimicrobial and/or anti-viral composition according to the present invention, wherein the components are kept separate from each other before application, the separate component (a) can be a composition that comprises H202 at a concentration of at least 10-50%v/v, such as at the most 10, 20, 30, 40 or 50% v/v. In one alternative, a composition of the present invention comprises H202 at a concentration of 30%v/v.
Emulsifier(s) and/or viscosity modifier(s) In some alternatives, the antimicrobial and/or anti-viral composition according to the present invention further comprises one or more emulsifier(s) and/or viscosity modifier(s). Said emulsifier and/or viscosity modifier may be selected from the group consisting of glycerine, glycols, polyethylene glycols (PEG), polyoxyethylene polyoxypropylene block copolymer (pluronic polyols), polyglycol alginate (PGA), CMC (carboxyl methyl cellulose), glycerol, Aloe Vera gel, alginate, hyaluronic acid (HA) and chitosan or any combination thereof.
The antimicrobial and/or anti-viral composition according to the present invention may also comprise one or more detergent(s) selected from the group consisting of SDS
(sodium dodecyl sulphate), sodium stannate, sodium pyrophosphate, oxine and SLS
(sodium lauryl sulphate) or any combination thereof.
The antimicrobial and/or anti-viral composition according to the invention may further comprise one or more fragrance or flavouring oil(s), such as, but not limited to perfumes and oils of spearmint, peppermint, wintergreen, sassafras, clove, sage, eucalyptus, marjoram, cinnamon and methyl salicylate or menthol or any combination thereof.
The antimicrobial and/or anti-viral composition according to the invention may further comprise one or more weak acidic buffers.
The antimicrobial and/or anti-viral composition according to the invention may further comprise one or more stabilizers such as, but not limited to organophosphates, carboxylate salts, sodium pyrophosphate, sodium phytate, colloidal stannate or sodium citrate or any combination thereof.
Bioactive substance Alternatively, or in addition, one or more of the compositions according to the present invention can comprise a bioactive substance, typically selected from the group consisting of EMD, peptides, drugs, bio active ions, small molecules, radioactive molecules, antimicrobial molecules and radio-opaque molecules or any combination thereof.
Cleaning components and antimicrobial substances What is more, one or more of the compositions according to the present invention can also comprise an additional antimicrobial substance and/or cleaning component.
In the present context, an additional antimicrobial substance provided in one or more of the compositions according to the present invention can be selected from the non-exclusive list consisting of amoxicillin, doxycycline, cephalexin, ciprofloxacin, clindamycin, metronidazole, azithromycin, sulfamethoxazole and trimethoprim or any combination thereof.
In one aspect, a further antimicrobial substance provided in one or more of the compositions according to the present invention is an alcohol, tetracycline, doxycycline, macrolides, penicillin (stabilized), chlorhexidine, chloramines or mixtures thereof.
In one aspect, one or more of the compositions according to the present invention comprises an additional anti-viral substance.
In one aspect, one or more of the compositions according to the present invention comprises an additional anti-inflammatory, antiphlogistic, coagulating, anesthetic and/or pain-killing agent or substance.
In one aspect, one or more of the compositions according to the present invention comprises one or more of prophylactic and/or anti-tooth-decay agents, such as, but not limited to, hydrogen fluoride, sodium fluoride, or stannous fluoride or any combination thereof.
Shelf-life of at least 1 years in room temperature (RT) A composition according to the present invention in one aspect has a shelf-life of at least 1 years at room temperature (RT).
A kit Aspects of the present invention also relate to a kit comprising a composition described herein, wherein said kit comprises at least two containers comprising said separated components (a) and (b), respectively, a syringe and a vial, a connector device, an applicator tip and an instruction leaflet and, optionally a mixing device and a cleaning tool, such as but not limited to a brush. Said kit can provide the two components (a) and (b) in a two-chamber syringe, in which case the kit further can comprise an instruction leaflet, a mixing device, an applicator tip and a cleaning tool, such as but not limited to a brush and/or a wipe.
An antimicrobial and/or anti-viral composition according to the present invention can be mixed before application and eventual storage or stored separately and mixed directly or shortly before and/or at the time of application. The application therefore, in another aspect is directed to a kit comprising a first container comprising component (a), a second container comprising component (b), and optionally at least one more (third or forth etc.) container comprising a component (c), (d), (e) etc.), which can e.g. comprise paper and/or cotton wipes, such as but not limited to wet-wipes, microparticles and/or a mesh-forming substance and/or a bioactive substance and/or a cleaning component and/or a further antimicrobial and/or anti-viral substance.
Optionally such a kit may also comprise instructions for the preparation of the composition of the invention. The kit may also comprise one or more device(s) for the application of the composition to a subject. Such a device may e.g. be a dispenser bottle, a blister pack, a double blister pack, a syringe and/or an implant cleaning and/or sanitizing tool for cleaning and/or sanitizing an implant, such as in the oral cavity.
A kit of the invention may also comprise one or more of the compositions described herein in one or more container(s) and an implant cleaning and/or sanitizing tool for cleaning and/or decontamination of an implant in the oral cavity.
In a presently preferred aspect, a kit comprising a composition according to the present invention typically provides the two components (a) and (b) in a two-chamber device that allows for easy mixing of the components prior to and/or or during application. Typically, such a device can be a two-chamber syringe, a two-chamber pump-action dispenser bottle a double blister (blister in blister) pack, or a wet-wipe blister containing a separate blister, containing peroxide, to be broken by force prior to application.
The kit can further comprise a container, such as a blister-pack and/or tissues, such as sanitizing wipes for applying the composition according to the present invention.
Uses The presently disclosed composition is intended for use in cleaning, sanitizing, disinfecting and/or sterilizing a biological surface and/or a biomaterial surface in situ.
In one aspect of the invention, the antimicrobial and/or anti-viral composition according the present invention is for use in sterilizing, disinfecting and/or sanitizing a biological surface and/or a biomaterial surface in situ.
Thus, an antimicrobial and/or anti-viral composition according to the present invention is typically used for cleaning, sterilizing, disinfecting and/or sanitizing skin and/or mucosa from microbes.
In particular, the microbes to be killed or removed by the composition according to the present invention are selected from the group consisting of bacteria and virus, such as selected from the non-exclusive group consisting of Riboviria, in particular Coronaviridae (e.g., Sars-Cov-2), or Orthocoronavirinae.
An antimicrobial and/or anti-viral composition according to the present invention is in particular well-suited for killing and/or removing Coronaviruses, such as from skin and/or mucosa, including from hands, face, or oral or nasal cavities.
10 The present invention thus in a presently preferred aspect also relates to the application of an antimicrobial and/or anti-viral composition according to the present invention as a hand wash, oral wash, tooth wash, for nasal and/or sinus cleansing, and/or for washing virus off skin and mucosa.
The desired formulations set forth herein are based on the combination of hydrogen peroxide (H202) and pluronic acid in such a concentration that the resulting composition is in a watery liquid form at physiological temperatures. The H202 component of the composition can either be in the form of a concentrate (at a concentration of at least 10-50%v/v.) in a separate vial for mixing immediately before use, or provided as an emulsion or dissolved directly into a hydrogel, said hydrogel at least partly consisting of pluronic acid and water and/or physiological saline, with a typical final concentration of 0.5 ¨ 7%.
The pluronic component itself can be any one or a combination of the pluronic acids, e.g.
the F-127 variety. The concentration of pluronic acid is typically 0.1-10% w/v, such as 0.1-7% w/v, such as 0.1-2.5% w/v. That is, the concentration of pluronic acid in any one or more of the compositions described herein can be at least or equal to 0.1%, 0.5%, 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%, 4.5%, 5.0%, 5.5%, 6.0%, 6.5%, 7.0%, 7.5%, 8.0%, 8.5%, 9.0%, or 10% w/v or a percentage w/v that is within a range defined by any two of the aforementioned percentages.
Pluronic-acid works both as solubilizer and detergent in the composition disclosed herein, as well as a moisturizer. In the presence of peroxide, the hydrogel formulation establishes a dynamic micelle forming solution. This dynamic state facilitates efficient solubilization and entrapment of particles, microbes and pollutants during the cleaning procedure (see e.g.
Figure 2).
The present innovation is based on a synergetic effect between pluronic acid and peroxide.
Pluronic acid has an ability to form micelles. This ability usually increases with increasing temperature and is shifted toward a gel state at physiological conditions (such as at >20 degrees Celsius). The peroxide addition allows the pluronic acid to stay in the liquid state even at physiological temperature.
When mixed with hydrogen peroxide, the present inventors for the first time disclose that the micelles are more dynamic and less stable and in a "dynamic" equilibrium with the peroxide radical activity even under high temperature. In effect, this means that in the presence of peroxide, the micelle structure is dissolved and reforms constantly also when the gel is applied onto human tissue, skin and/or mucosa. This effect keeps the hydrogel liquid also at high temperatures and increases the detergent, denaturation and entrapment effect of the pluronic acid significantly.
Combined with the effect of hydrogen peroxide to release free oxygen radicals on viral particles, microbes and necrotic tissue, the micelle transitions dissolve and entrap organic contamination that are then removed when the gel dries off, is wiped off, or washed off.
5 Desirably, the addition of hydrogen peroxide to the pluronic acid in the compositions described herein increases the temperature at when gelation occurs. e.g., that the pluronic gel, containing low concentrations of peroxide, is liquid at room temperate and thus can be applied through a syringe needle or from a dispenser bottle without clogging the nozzle. This is not possible with pluronic acid alone because it starts forming a stable "packed micelle"
10 gel already at room temperature, even at low concentrations when in narrow compartments and/or at the "vapor front" at the nozzle of the dispenserõ thus is very hard to squeeze through a narrow tip of a syringe, or a pump applicator from a dispenser bottle. pluronic gel for wound care is therefore sold as gel in a box or a tube. The increased effect from the combination of peroxide and pluronic acid was unexpected and surprising.
The liquid formulation of the pluronic hydrogel in combination with peroxide also assists during application. It enables the cleaning and/or sanitizing composition to reach folds, wrinkles, crevices, fissures, narrow spaces and/or undercuts that a pluronic gel alone cannot reach because of its gel forming nature making it viscous at physiological temperatures.
Thus, it is more efficient in cleaning rough (implant) surfaces, narrow spaces such as folds, fissures and wrinkles on skin and mucosa and between teeth.
Compositions Aspects of the present invention relate to novel antimicrobial and/or anti-viral compositions, which can be used for cleaning, sanitizing, sterilizing, disinfecting and/or decontaminating a biological surface and/or a biomaterial surface in situ. In some alternatives, the aforementioned compositions comprise two components:
a. H202 at a final concentration of between 0.1 - 7%v/v, and b. a composite hydrogel formulation of pluronic acid at a concentration of 0.1 - 10%w/v.
In some of the aforementioned compositions, the final concentration of H202 is at least or equal to 0.1%, 0.5%, 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%, 4.5%, 5.0%, 5.5%, 6.0%, 6.5%, or 7.0% w/v or a percentage w/v that is within a range defined by any two of the aforementioned percentages. In some of the aforementioned compositions, the final concentration of pluronic acid is at least or equal to 0.1%, 0.5%, 1.0%, 1.5%, 2.0%, 2.5%, 3.0%, 3.5%, 4.0%, 4.5%, 5.0%, 5.5%, 6.0%, 6.5%, 7.0%, 7.5%, 8.0%, 8.5%, 9.0%, or 10%
w/v or a percentage w/v that is within a range defined by any two of the aforementioned percentages.
Preferably, said compositions are formulated so that they remain a liquid at physiological temperatures, such as at a temperature of at the most 40 C, such as at a temperature between 20-40 C, such as at 37 C e.g., 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, or 40 C or at a temperature that is within a range defined by any two of the aforementioned temperatures.
Some of the presently disclosed compositions are characterized in that they comprise a low concentration of pluronic acid, which allows the composition to be in a liquid state in high temperature instead of in a gel-state, which a desirable feature for it to be usable for cleaning, sanitizing, sterilizing, disinfecting and/or decontaminating a biological surface and/or a biomaterial surface in situ. In particular, the liquid state of the hydrogel is desired when the composition is incorporated into a hand sanitizer, hand wash, oral wash and/or for nasal and/or sinus cleansing solution, in particular for washing virus off of skin and mucosa.
The presently disclosed compositions comprise the at least two components (a) and (b) in such a ratio that the composition is in a liquid state at physiological temperatures instead of in a more viscous or gel-like state. Typical ratios of concentrations between component (a) and component (b) are approximately 1:1 (concentration of H202: concentration of pluronic acid). In general, the higher the concentration of the pluronic acid, the higher the concentration of the H202 is needed to keep the composition in a liquid state at temperatures of between 25-40 C. However, too high concentrations of peroxide will destroy the pluronic acid amphiphilic properties and disrupt micelle formation, rendering it useless as a detergent and/or a desatu rating agent.
In one alternative of an antimicrobial and/or anti-viral composition according to the present invention, the composite hydrogel formulation of component (b) comprises pluronic acid at a concentration of 0.1-10%w/v, such as at a concentration of 10% w/v, such as of 0.1, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9 or 9.5 %w/v or an amount that is within a range defined by any two of the aforementioned concentrations.
In another alternative of an antimicrobial and/or anti-viral composition according to the present invention, the composite hydrogel formulation of component (b) comprises pluronic acid at a concentration of at the most 10% w/v, such as at the most 0.1, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9 or 9.5 %w/v or an amount that is within a range defined by any two of the aforementioned concentrations.
An antimicrobial and/or anti-viral composition according to the present invention can be a composition wherein the H202 of component (a) has a final concentration of 0.1-7%v/v, such as 0.5-3%v/v, such as 0.1-5 /0v/v. In one embodiment, the H202 of component (a) has a final concentration of no more than 7%v/v, such as 0.1-7`)/ov/v, such as 1, 2, 3, 4, 5, 6 or 7%v/v.
An antimicrobial and/or anti-viral composition according to the present invention can further comprise water and/or physiological saline.
The two components of the antimicrobial and/or anti-viral composition according to the present invention can be in one solution or the at least two components can be kept separate from each other such that they can be simultaneously mixed and applied to a biological surface and/or a biomaterial surface in situ.
In an antimicrobial and/or anti-viral composition according to the present invention, wherein the components are kept separate from each other before application, the separate component (a) can be a composition that comprises H202 at a concentration of at least 10-50%v/v, such as at the most 10, 20, 30, 40 or 50% v/v. In one alternative, a composition of the present invention comprises H202 at a concentration of 30%v/v.
Emulsifier(s) and/or viscosity modifier(s) In some alternatives, the antimicrobial and/or anti-viral composition according to the present invention further comprises one or more emulsifier(s) and/or viscosity modifier(s). Said emulsifier and/or viscosity modifier may be selected from the group consisting of glycerine, glycols, polyethylene glycols (PEG), polyoxyethylene polyoxypropylene block copolymer (pluronic polyols), polyglycol alginate (PGA), CMC (carboxyl methyl cellulose), glycerol, Aloe Vera gel, alginate, hyaluronic acid (HA) and chitosan or any combination thereof.
The antimicrobial and/or anti-viral composition according to the present invention may also comprise one or more detergent(s) selected from the group consisting of SDS
(sodium dodecyl sulphate), sodium stannate, sodium pyrophosphate, oxine and SLS
(sodium lauryl sulphate) or any combination thereof.
The antimicrobial and/or anti-viral composition according to the invention may further comprise one or more fragrance or flavouring oil(s), such as, but not limited to perfumes and oils of spearmint, peppermint, wintergreen, sassafras, clove, sage, eucalyptus, marjoram, cinnamon and methyl salicylate or menthol or any combination thereof.
The antimicrobial and/or anti-viral composition according to the invention may further comprise one or more weak acidic buffers.
The antimicrobial and/or anti-viral composition according to the invention may further comprise one or more stabilizers such as, but not limited to organophosphates, carboxylate salts, sodium pyrophosphate, sodium phytate, colloidal stannate or sodium citrate or any combination thereof.
Bioactive substance Alternatively, or in addition, one or more of the compositions according to the present invention can comprise a bioactive substance, typically selected from the group consisting of EMD, peptides, drugs, bio active ions, small molecules, radioactive molecules, antimicrobial molecules and radio-opaque molecules or any combination thereof.
Cleaning components and antimicrobial substances What is more, one or more of the compositions according to the present invention can also comprise an additional antimicrobial substance and/or cleaning component.
In the present context, an additional antimicrobial substance provided in one or more of the compositions according to the present invention can be selected from the non-exclusive list consisting of amoxicillin, doxycycline, cephalexin, ciprofloxacin, clindamycin, metronidazole, azithromycin, sulfamethoxazole and trimethoprim or any combination thereof.
In one aspect, a further antimicrobial substance provided in one or more of the compositions according to the present invention is an alcohol, tetracycline, doxycycline, macrolides, penicillin (stabilized), chlorhexidine, chloramines or mixtures thereof.
In one aspect, one or more of the compositions according to the present invention comprises an additional anti-viral substance.
In one aspect, one or more of the compositions according to the present invention comprises an additional anti-inflammatory, antiphlogistic, coagulating, anesthetic and/or pain-killing agent or substance.
In one aspect, one or more of the compositions according to the present invention comprises one or more of prophylactic and/or anti-tooth-decay agents, such as, but not limited to, hydrogen fluoride, sodium fluoride, or stannous fluoride or any combination thereof.
Shelf-life of at least 1 years in room temperature (RT) A composition according to the present invention in one aspect has a shelf-life of at least 1 years at room temperature (RT).
A kit Aspects of the present invention also relate to a kit comprising a composition described herein, wherein said kit comprises at least two containers comprising said separated components (a) and (b), respectively, a syringe and a vial, a connector device, an applicator tip and an instruction leaflet and, optionally a mixing device and a cleaning tool, such as but not limited to a brush. Said kit can provide the two components (a) and (b) in a two-chamber syringe, in which case the kit further can comprise an instruction leaflet, a mixing device, an applicator tip and a cleaning tool, such as but not limited to a brush and/or a wipe.
An antimicrobial and/or anti-viral composition according to the present invention can be mixed before application and eventual storage or stored separately and mixed directly or shortly before and/or at the time of application. The application therefore, in another aspect is directed to a kit comprising a first container comprising component (a), a second container comprising component (b), and optionally at least one more (third or forth etc.) container comprising a component (c), (d), (e) etc.), which can e.g. comprise paper and/or cotton wipes, such as but not limited to wet-wipes, microparticles and/or a mesh-forming substance and/or a bioactive substance and/or a cleaning component and/or a further antimicrobial and/or anti-viral substance.
Optionally such a kit may also comprise instructions for the preparation of the composition of the invention. The kit may also comprise one or more device(s) for the application of the composition to a subject. Such a device may e.g. be a dispenser bottle, a blister pack, a double blister pack, a syringe and/or an implant cleaning and/or sanitizing tool for cleaning and/or sanitizing an implant, such as in the oral cavity.
A kit of the invention may also comprise one or more of the compositions described herein in one or more container(s) and an implant cleaning and/or sanitizing tool for cleaning and/or decontamination of an implant in the oral cavity.
In a presently preferred aspect, a kit comprising a composition according to the present invention typically provides the two components (a) and (b) in a two-chamber device that allows for easy mixing of the components prior to and/or or during application. Typically, such a device can be a two-chamber syringe, a two-chamber pump-action dispenser bottle a double blister (blister in blister) pack, or a wet-wipe blister containing a separate blister, containing peroxide, to be broken by force prior to application.
The kit can further comprise a container, such as a blister-pack and/or tissues, such as sanitizing wipes for applying the composition according to the present invention.
Uses The presently disclosed composition is intended for use in cleaning, sanitizing, disinfecting and/or sterilizing a biological surface and/or a biomaterial surface in situ.
In one aspect of the invention, the antimicrobial and/or anti-viral composition according the present invention is for use in sterilizing, disinfecting and/or sanitizing a biological surface and/or a biomaterial surface in situ.
Thus, an antimicrobial and/or anti-viral composition according to the present invention is typically used for cleaning, sterilizing, disinfecting and/or sanitizing skin and/or mucosa from microbes.
In particular, the microbes to be killed or removed by the composition according to the present invention are selected from the group consisting of bacteria and virus, such as selected from the non-exclusive group consisting of Riboviria, in particular Coronaviridae (e.g., Sars-Cov-2), or Orthocoronavirinae.
An antimicrobial and/or anti-viral composition according to the present invention is in particular well-suited for killing and/or removing Coronaviruses, such as from skin and/or mucosa, including from hands, face, or oral or nasal cavities.
10 The present invention thus in a presently preferred aspect also relates to the application of an antimicrobial and/or anti-viral composition according to the present invention as a hand wash, oral wash, tooth wash, for nasal and/or sinus cleansing, and/or for washing virus off skin and mucosa.
15 The present invention thus in a presently preferred aspect also relates to the application of an antimicrobial and/or anti-viral composition according to the present invention as a hand sanitizer, mouth wash, sinus rinse, nasal rinse and/or sanitizing wipes.
The presently disclosed composition is also useful for application in pen-implant defects, and 20 the formulation may be tailored to fit with various clinical procedures, such as but not limited to treating and preventing oral infections , for maintaining oral and/or nasal health and post-operative follow-up administrations to skin, mucosa and/or oro-laryngeal and/or nasal cavities.
The presently disclosed composition can also be used for other oral procedures, such as during surgical cleaning of periodontal defects, for preparation before regenerative procedures, in periodontal maintenance treatment, in periodontitis prophylaxis (by dental hygienists), as well as in endodontics, both in root-canal procedures and in apical surgery.
What is more, the presently disclosed composition can further be used for cleaning and/or debriding outside the oral cavity, such as, but not limited to in orthopaedic revision surgery, sanitizing of transdermal devices, in dermal wound care for cleaning of acute wounds and/or in cleaning of chronic ulcers and burns.
An antimicrobial and/or anti-viral composition according to the present invention can typically be employed for use in the treatment and/or prevention of peri-implantitis, gingivitis and/or mucositis, pen-implant mucositis and/or periodontitis or for the sanitizing of the oral cavity against contagious disease or prior to oral surgery procedures.
Periimplantitis is a typical complication related to orodental rehabilitation through the use of implants, e.g., a pen-implant disease, which is well-known to the person skilled in the art as an inflammatory reaction to oral microbes in which there is an accompanied loss of the bony support of the implant. The aetiology of the disease is conditioned by the status of the tissue surrounding the implant, implant design, degree of roughness, the poor alignment of implant components, external morphology and excessive mechanical load.
The presently described antimicrobial and/or anti-viral composition offers several approaches for an effective and rapid cleaning of an implant and/or for sanitizing or decontaminate a tissue surface in the oral cavity essentially without damaging of the delicate structure or of the implant surface and/or the tissue surface itself, and essentially without leaving contaminating material residues on the treated surface.
The invention therefore in one aspect is directed to the antimicrobial and/or anti-viral composition as defined herein and/or the kit for preparing the composition of the invention as defined herein, for use as a medical device or a medicament.
Thus, the present invention relates to the use of an antimicrobial and/or anti-viral composition according to the present invention for cleaning and/or sanitizing and/or decontaminate an implant in the oral cavity, such as an implant in situ, a tissue surface in the oral cavity, such as an outer surface of a tissue in the oral cavity, a surgically exposed surface in the oral cavity, a wound in the oral cavity, such as a wound resulting from periimplantitis or a surgical wound, a periodontal defect and/or periodontal wound, and/or an oral hard tissue defect.
Implants The invention also relates to the use of the antimicrobial and/or anti-viral composition as defined herein and/or the kit for preparing the composition of the invention as defined herein, for the preparation of a medicament and/or a pharmaceutical and/or cosmetic composition, for cleaning and/or decontaminating an implant in the oral cavity, such as an implant in situ, a hard surface in the oral cavity, such as an outer surface of a hard tissue in the oral cavity, a surgically exposed hard surface in the oral cavity, a wound in the oral cavity, such as a wound resulting from periimplantitis or a surgical wound, a periodontal defect and/or periodontal wound, and/or an oral hard tissue defect.
The invention is also directed to the antimicrobial and/or anti-viral composition as defined herein or the kit for preparing the composition of the invention as defined herein for use cleaning, sanitizing, disinfecting, sterilizing and/or debriding an implant in the oral cavity, such as an implant in situ, a hard surface in the oral cavity, such as an outer surface of a hard tissue in the oral cavity, a surgically exposed hard surface in the oral cavity, a wound in the oral cavity, such as a wound resulting from periimplantitis or a surgical wound, a periodontal defect and/or periodontal wound, and/or an oral hard tissue defect.
Oro-laryngeal and nasal medical applications In dentistry and otorhinolaryngology, nasal and mouth rinses are used pre- and post-surgery to lower the microbial burden during a procedure, or to treat infections. The infection of oro-larynx and nasal mucosa leads to formation of mucus that can fill up sinuses and cause nasal and sinus congestion and microbe accumulation on tongue, tonsils, teeth and gums.
The invention is also directed to the antimicrobial and/or anti-viral composition as defined herein for use as mouth wash, nasal rinse and/or sinus rinse for the disinfection and cleaning of oral, laryngeal and/or nasal anatomical structures and/or surfaces.
Microorganisms An antimicrobial and/or anti-viral composition according to the present invention is in general intended for use in cleaning, disinfecting, sanitizing and/or decontaminating a biological surface and/or a biomaterial surface in situ, e.g. for use in removal of virus, microbes, including but not limited to bacteria, yeasts, and bacterial spores, and dirt from such a biological surface and/or a biomaterial surface in situ.
Biofilms that can be prevented, eliminated and/or treated by the composition of the present disclosure include, but are not limited to, biofilms present within the oral cavity, e.g., on the surface of teeth, on the surface of mucosal/soft-tissues such as gingivae/periodontium and inside a tooth canal (e.g. the endodontic canal).
In certain embodiments, biofilms that can be prevented, eliminated and/or treated by the composition of the present disclosure include biofilms on the urinary tract, lung, gastrointestinal tract, on and/or within chronic wounds, and present on the surface (e.g., implants) and within medical devices and medical lines, e.g., catheters, medical instruments or medical tubing.
The composition of the present disclosure can be used to reduce the growth and/or inhibit the viability of one or more microorganisms, e.g., bacteria in a biofilm. For example, and not by way of limitation, the bacteria, which can be inhibited can include Streptococcus mutctns (S. mutctns), Streptococcus sobrinus, Streptococcus sctnguis (sctnguinis), Streptococcus gordonii, Streptococcus omlis, Streptococcus mitis, Actinomyces odontolyticus, Actinomyces viscosus, Aggregcttibctcter ctctinomycetemcomitctns, lctctobctcillus spp., Porphyromoncts gin givctlis, Prevotellct intermedia, Bacteroides forsythus, Treponema denticola, Fusobacterium nucleatum, Campylobacter rectus, Eikenella corrodens, Veillonella spp., Micromonas micros, Porphyromonas cangingivalis, Haemophilus actinomycetemcomitans Actinomyces spp., Bacillus spp., Mycobacterium spp., Fusobacterium spp., Streptococcus spp., Staphylococcus aureus, Streptococcus pyogenes, Streptococcus agalectiae, Proteus mirabilis, Elebsiella pneumoniae, Acinetobacter spp., Enterococcus spp., Prevotella spp., Porphyromonas spp., Clostridium spp., Stenotrophomonas maltophilia, P.
cangingivalis, Candida albicans, Escherichia coil and/or Pseudomonas aeruginosa. In certain embodiments, the bacteria are S. mutans, which is present within biofilms found in the oral cavity, e.g., on the surface of teeth.
The microorganisms most commonly associated with implant failure are spirochetes and mobile forms of Gram-negative anaerobes. Diagnosis can be based on changes of colour in the gum, bleeding and probing depth of pen-implant pockets, suppuration, x-ray and gradual loss of bone height around the tooth. The antibiotic therapy proven to be most efficacious in the antibiogram has so far been the association of amoxycillin and clavulanic acid. In addition to bacterial infections, microbial infections in the oral cavity can of course also include fungal and/or viral infections.
An antimicrobial and/or anti-viral composition according to the present invention is effective for killing bacteria, fungus and/or virus.
Typically, a composition according to the present invention is for use in cleaning skin and/or mucosa from virus such as, but not limited to, Riboviria, such as Coronaviridae, such as Orthocoronavirinae and Orthomyxoviridae such as Influenza A, B, C and D virus, Arbo virus and lsavirus, and such as Rotavirus, Noro virus, Adenovirus, Papillomavirus, Herpes virus, Hepatitis virus, Small Pox virus, Parvo virus, Ebola virus, Measles virus or Rabies virus.
In a presently preferred aspect, a composition according to the present invention is for use in cleaning skin and/or mucosa from Coronavirus or Influenza virus.
What is more, the composition described herein is antimicrobial, without causing microbial resistance, as well as anti-viral.
In consequence, the present invention relates to a method for cleaning, sanitizing, treating and /or preventing contagious diseases, infections, gingivitis and/or mucositis, pen-implant mucositis, peri-implantitis, periodontitis, tooth decay, and/or sinusitis and rhinitis, comprising cleaning of a biological surface and/or a biomaterial surface in situ by applying a composition according to the present invention to said fouled, filmed and/or contaminated structure, tissue or surface.
EXAMPLES
The following Examples have been included to provide guidance to one of ordinary skill in the art for practicing representative embodiments of the presently disclosed subject matter.
Considering the present invention and the general level of skill in the art, those of skill can appreciate that the following Examples are intended to be exemplary only and that numerous changes, modifications, and alterations can be employed without departing from the scope of the presently disclosed subject matter.
Example 1 Analysis of micelle formation of pluronic in presence of peroxide Pluronic F-127 added to an aqueous solution can change its thickness depending on the concentration and temperature. F-127 is a non-ionic, surfactant polyol with a molecular weight of 12500 Daltons.
As can be seen in figure 1, gel boundaries for aqueous saline (physiological conditions) solutions of copolymer F-127. The filled circles are data points obtained by the tube inversion method for the mixture. The unfilled squares are data points from rheometric analyses. The chart clearly indicates that pluronic concentrations below 15% w/v in saline remains fluid independent of temperature. Fluid pluronic solutions form independent micelles, but the concentration is not high enough for the pluronic micelles to assemble into a cubic gel. Thus, low pluronic concentrations that allow for micelle formation but stay liquid and act as detergent may be good for tissue-friendly cleaning of biological surfaces, but addition of other potent reactants that can contribute to the decontamination is expected to completely disrupt the micelle formation and thus abolish the wanted detergent and denaturing effects.
Adding Peroxide to the Pluronic f-127 gel In order to test if micelle formation (as visualised by ability to foaming and dissolve oil) still could be obtained when mixing low concentration of Pluronic f-127 in water with various antimicrobial agents (see example 3), hydrogen peroxide, in a wide range of peroxide concentrations, was tested (Table 1).
The technique used for making aqueous poloxamer solution is simple. Weighed amount of the f-127 is slowly added to a known weight of cold water (less than 10 C) with careful stirring.
The stirring rate should be controlled so as to maintain a slight vortex in the liquid. Too rapid a stirring rate will cause aeration and the formation of foam.
Sample Pluronic F-127(gr) H20 (ml) 50% H202(m1) 0 2.5 50.00 0.00 (0.0%) 1 2.5 49.90 0.10 (0.1%) 2 2.5 49.50 0.50 (0.5%) 3 2.5 49.00 1.00 (1.0%) 4 2.5 48.50 1.50 (1.5%) 5 2.5 47.00 3.00 (3.0%) 6 2.5 44.00 6.00 (6.0%) 7 2.5 38.00 12.00 (12.0%) Table 1: Compositions of suspensions containing 5% pluronic Acid F-127 (Zigma Aldrich) in water and a range of Hydrogen Peroxide (Sigma Aldrich). After dissolving the f-127 in cold water, the right amount of hydrogen peroxide was added, mixing was done by inverting tubes 5 carefully to avoid foaming, and the solutions were left on the bench at room temperature for 10 minutes. When all the polymer has been added, stirring can be continued (while keeping the solution cool) until a clear solution is formed or the container can be placed in a refrigerator and left undisturbed for several hours, at which time solution is complete.
The H202 was mixed in by slight stirring for a few seconds when the experiment started.
Sample Foaming (0-3) Oil absorption per % of H202 50 ml (droplets) 0 3 7 0.00 1 2 6 0.1%
2 3 12 0.5%
3 3 11 1.0%
4 3 7 1.5%
5 2 5 3.0%
6 1 2 6.0%
7 1 0 12.0%
Table 2: After incubation all the solutions were still liquid (no gel formation as expected) and were vortexed and the ability to form foam (as a simple measurement of surfactant effect) was scored on a scale from 0 (no foam) to three (much foam). As expected, sample 0 scored maximum, and addition of hydrogen peroxide reduced foaming at low and high concentration.
Unexpectedly there were no linearity in the reduction of foaming. In fact, samples 2 trough 4 scored as high as the control, indicating that micelle formation and surfactant effect were preserved in these samples. The samples were then tested on how many oil droplets (mineral oil stained with oil red (Sigma Aldrich)) from a needle point the solutions could absorbed before getting turbid. Turbidity is a sign of macro-emulsion, a stage where oil droplets become so big that they disperse light. The positive control, Sample 0, absorbed 7 oil droplets before getting turbid. The negative control, sample 7, turned turbid with the first droplet.
The expected linearity between these extremes was however not observed. Surprisingly, sample 2 (0.5%
Peroxide) and 3 (1.0% peroxide) actually absorbed almost twice as many droplets than the positive control before turbidity was observed. This indicates that Pluronic f-127 micelle formation at low concentrations (=liquid solutions) actually is more efficient, and dynamic, in presence of low concentrations of hydrogen peroxide in the range of 0,5 ¨ 1,5%
volume by volume (in a 5% w/v solution of f-127).
Example 2 Test of biocompatibility of pluronic acid combined with peroxide Test procedure:
The biocompatibility test was performed according to ISO 10993-5:2009 Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity.
Colorimetric assay such MTT, WST-1 or LDH was not used as the peroxide suspension degrade the indicator colour used in these assays and thus, they cannot be used. Instead radioactive labelling with [3H] thymidine incorporation was used to analyse the cytotoxicity of the pluronic-peroxide solution on normal human dermal fibroblast cells (NHDF) (Lonza Walkersville, Inc. Walkersville, MD, USA).
Due the viscosity of the tested hydrocolloid gels (SilvaSorb0 Gel, Medline Industries, Munedelein, IL) and the pluronic-Peroxide gels (20%Pluronic f-127 in water with 3%
Hydrogen Peroxide), the test samples could not be diluted into the cell culture medium. Nor could the NHDF cells grow directly onto the gel due their lack of surface properties. To overcome this problem, the NHDF cells were grown on cell culture inserts (Millice110, Millipore Corp., Billerica, MA, USA) that was inserted into a well that contained the test gel diluted 1:1 against cell culture medium. The NHDF cells were cultivated in 24 well plates for 24 hours at 37C and 5% CO2 with Dulbecco's PBS cell culture media (FGM0-2 with Insulin (CC-4021J), rhFGF-B (CC-4065J) and FBS (CC-4161J), Lonza Walkervill, MD USA).
After 24 hours growing in presence of test substances or controls (no gel and gelatin gel) 0.5 pL
3H-thymidine (Perkin Elmer, Boston, USA) was added into the wells containing the cells. After 12 hours of exposure to thymidine the cells were washed three times in cold PBS and lysed with 250pL 1M NaOH. Then 200pL of the solubilized cell solution was transferred to 3m1 Insta-gel-2-Pluss liquid scintillation fluid. Subsequently the scintillations were counted in a liquid scintillation analyser (TRI-Corb0 1500 Perkin Elmer).
Results and conclusion: There were no observed difference in count number between samples exposed to pluronic-Peroxide solution and the controls indicating that the NHDF
cells grew at normal rate in presence of these test gels. The hydrogen peroxide containing pluronic acid gels are safe and biocompatible. The SilvaSorb gel showed a significant decrease in count number indication slower cell growth in presence of this gel as has also been repeatedly reported in the scientific literature, indicating that this gel is slightly toxic NHDF cells.
Example 3 Chemical cleaning efficacy of liquid Pluronic f-127 solutions containing peroxide The following cleaning solutions were tested:
Negative control Brain Heart Infusion Broth (BHI broth) Test 1 H202 3% v/v + f-127 1% w/v Test 2 H202 5% v/v + f-127 1% w/v Test 3 H202 3% v/v + f-127 7% w/v Test 4 H202 5% v/v + f-127 7% w/v Test 5 Chlorhexidine 0.2% w/v + f-127 7% w/v Test 6 Ethanol 75% v/v + f-127 1% w/v Experimental set-up:
A stock Streptococcus Epidermidis culture was established in BHI broth and allowed to grow to log phase.
The S. Epidermidis culture was introduced to cell culture disks of c.p.
titanium and allowed to for a multilayer biofilm on the surface over a period of 2 days. After the biofilm had been established, the discs were rinsed several times in sterile, cold PBS until only adherent cells was present on the surfaces.
The discs with biofilm on were then submerged in test gel or control for 5 minutes 5 sec.
making sure that the entire discs were covered by the test gels all the time.
The discs were then rinsed for 10 minutes in cold PBS on a shaker, rinsed off and viewed in a table-top scanning electron microscope to see how many bacteria that were left on the test surfaces.
Results and conclusion:
This experiment showed that cleaning efficacy increased some with increasing H202 and increasing Pluronic f-127 concentration. The difference between test 1 and test 4 was however surprisingly small and not statistically significant, as all four tests performed very well and almost no bacteria remained on the surface. The negative control was as expected completely covered by bacteria with no effect of the PBS washing. The positive Chlorhexidine and Ethanol controls was surprisingly ineffective. Almost all of the biofilm was retained on the surfaces in these two groups. Later analysis with regrowth of bacteria from these surfaces revealed that all bacteria in these two tests were dead, but that the bulk of the biofilm remained attached to the surface, forming a contaminated layer that provide a strong bridgehead for new biofilm formation if a new contamination occurs.
The surprising finding in this study is that it seems to be a synergistic effect between hydrogen peroxide and Pluronic f-127 that not only kills bacteria but also disintegrate and solubilize the entire biofilm, leaving an almost totally decontaminated surface (Figure3). The concentration of the peroxide and pluronic can be reduced toward 3% hydrogen peroxide in 1% pluronic acid without losing much effect compared to stronger solutions.
This also indicates that the synergy between hydrogen peroxide and pluronic acid can be fine-tuned and probably has an optimal concentration-relation that allows for rapid and dynamic micelle (detergent and denaturation) effect and at the same time maintains the effectiveness of activated oxygen release that kills microbes and dissolves organic molecules.
This optimal formulation appears to be lower in concentration of both peroxide and pluronic when the components are mixed together than what one would expect based on the effect of the separate components.
As is shown in Figure 3, titanium surfaces contaminated with S. Epidermidis bacteria was cleaned with growth medium (BHI, Negative control), H202 5% v/v + f-127 1% w/v (Test 2), H202 5% v/v + f-127 7% w/v (Test 4), Chlorhexidine 0,2% w/v + f-127 7% w/v (Test 5) or Ethanol 75% v/v + f-127 1% w/v. The negative control did not remove the bacteria, nor was the bacteria destroyed. The peroxide + pluronic acid mix killed all bacteria, dissolved the biofilm and removed the debris almost completely (Tests 2 & 4). Test 4 was slightly, but not statistically significant, more effective than Test 2. Chlorhexidine (Test 5) and Ethanol (Test 6) did kill most of the bacteria but did not remove any debris from the surface, leaving the surfaces heavily contaminated. Surfaces visualized after cleaning in a scanning electron microscope. Scale bar is 20 micrometres.
Example 4 Staining of living and dead bacteria on decontaminated surfaces Titanium surfaces contaminated with S. Epidermidis bacteria and grown to biofilm in BHI
broth was removed from growth medium and submerged in sanitizing solution for 5 minutes on a slow shaker. Discs were sanitized with A) saline (Negative control), B) Chlorhexidine 0.2% w/v, or C) H202 3% v/v + f-127 pluronic Acid 5% w/v. After cleaning the surfaces were stained with fluorescent dyes, green for living microbes and red for dead microbes. The negative control (saline) did not remove any of the microbes, nor was the biofilm removed.
The chlorhexidine killed all microbes but left the dead cells to contaminate the surface. The hydrogen peroxide + pluronic acid mix killed all microbes, dissolved the biofilm and removed the contamination almost completely. Surfaces were visualized in a confocal microscope after cleaning and staining (Figure 4).
Example 5 Regrowth of S. Epidermidis after sanitizing a contaminated titanium surface Regrowth of S. Epidermidis bacteria harbouring the luciferase gene making them fluorescent, on sanitized titanium surfaces. Surfaces was first contaminated with bacteria and incubated in BHI broth until the surfaces were completely covered in biofilm. The titanium discs were then submerged in sanitizing solution and left on a slow shaker for 5 minutes. After sanitizing the discs were rinsed in a large volume of sterile water, then covered by BHI medium again and incubated at 37 centigrade. At hourly intervals the discs were placed in a fluorometer to measure regrowth of bacteria by amount of fluorescent as compared to an untreated calibrated control and a sterile disc. The results show (see figure 5B) that D) water with detergent (SDS 0,1% w/v), E) water with 5% pluronic acid and F) saline had minimal sanitizing effect, as regrowth of the biofilm occurred within 3-4 hours after cleaning. Chlorhexidine, 0,2%, on the other hand killed all bacteria with no regrowth observed although the dead biofilm stuck and remained on the surface (see figure 3 and 4).
Hydrogen peroxide, 5% v/v, alone (A) cleaned the surface well as seen by a delay of about 13 hours before the biofilm restored itself. However, hydrogen peroxide 3% v/v combined with 5% pluronic acid in water cleaned the surface significantly better, delaying regrowth with more than 15 hours (see also Figure 5A).
Example 6 Pluronic with peroxide is more skin-friendly than an alcohol containing hand-sanitizer Left and right thumbs were washed and sanitized four times daily for five consecutive days with a mix of A) pluronic acid (5% w/v) and hydrogen peroxide (3% v/v) or B) Antibac PharmaTM containing ethanol and propan-2-ol respectively. After completion of the 5th day sanitizing procedure both fingers were stained with a solution of Indian Red (iron oxide) to visualize fissures and cracks in the skin. After staining the fingers were washed thoroughly in warm water with soap, left to air dry and photographed in daylight. Fissures and cracks in the skin of the thumbs are easily visible as striated brown staining. The Antibac PharmaTM
treated finger show deep fissures and cracks with callous, dry and hard skin.
The pluronic-peroxide formulation however, caused no harm to the skin of the left thumb, leaving skin intact and tender. This demonstrate that the pluronic-peroxide formulation is more biocompatible and tissue friendly than alcohol-based hand sanitizers (Figure 6).
Example 7 Efficiency of sanitizing solutions on removing organic contaminants To demonstrate the ability of hand sanitizers and cleaning solutions to remove stains and contamination from skin, a panel of products and solutions were tested against stains of permanent ink. Fingers were marked with a line of permanent blue ink (LyrecoTM
permanent marker for laboratory use). The ink was applied with a pen and left to air-dry for approx. 5 minutes. The fingers were then cleaned with the various sanitizing solutions for about 6-8 seconds, mimicking the normal application time for hand sanitizers in daily life. The sanitizing agent was thoroughly wiped off with paper tissue and the fingers were photographed with an iPhone X in daylight using the automatic exposure control. The 5 intensity of the remaining stain is regarded to be an inverse visual gauge for the cleaning efficacy of the tested solutions. Finger A) was washed only with water. Finger B) was cleaned with warm water and soap. Finger C) was cleaned with 0.2%
chlorhexidine and finger D) was rinsed with PyrispetTM (0.1% cetyl-pyridinium chloride). Finger E) was cleaned with Antibac PharmaTM (Alcohol based sanitizer containing ethanol and propan-2-ol), finger 10 F) was cleaned with bleach (4% Sodium hypochlorite). Finger G) and H) was rinsed with hydrogen peroxide (1% and 5% v/v in water respectively). Finger I) was washed in a solution of pluronic acid f-127 in water (5% w/v). Finger J) was sanitized with a mix of pluronic acid (5% w/v) and hydrogen peroxide (1% v/v). The results show that bleach and hydrogen peroxide is very effective in removing the permanent ink stain. However, surprisingly, the 15 most efficient removal of the stain is obtained by the combination of pluronic acid and weak hydrogen peroxide (Figure 7).
Example 8 Application for skin sanitizing, two-chamber dispenser bottle.
20 The two-component pluronic-Peroxide solution described here is intended for hand sanitizing after possible exposure to virus contamination. Virus are genetic code (RNA or DNA) wrapped in a protein envelope to protect and transmit the genetic information.
Most sanitizers only attack (denature or fix) the protein envelope so that the virus is no longer very contagious, but do not remove the virus per se or attack the virus genome. The combination 25 of peroxide and pluronic do both. The peroxide degrades both proteins and RNA and DNA, and the pluronic also denatures proteins and dissolves the organic material into its micelle structure, completely destroying and removing the viral particles from the skin, together with other contaminants and dirt.
30 A 500 ml dispenser bottle is divided in two chambers; one containing 400 milliliters of f-127 pluronic acid at 10% w/v in water, and one chamber containing 100 milliliters of Hydrogen Peroxide 25% v/v in water. A pump with two inlets pumps liquid from both chambers into the dispenser tip for mixing and application. The mixed solution is evenly distributed over the hands as with any other sanitizer, left to work for some seconds and is then rinsed off under running tap water. There is no need to apply any soap as the liquid itself also work as a detergent. The clean hands are dried off with a paper towel or air dried. No extraordinary precautions or actions are necessary to remove the solution. The solution is completely harmless after rinsing and will decompose to water, oxygen and carbon dioxide with no environmental footprint or impact.
Example 9 Application for skin sanitizing, dispenser bottle with emulsion.
The two-component pluronic-peroxide solution described here is intended for hand sanitizing after possible exposure to virus contamination. Virus are genetic code (RNA or DNA) wrapped in a protein envelope to protect and transmit the genetic information.
Most sanitizers only attack (denature or fix) the protein envelope so that the virus is no longer very contagious, but do not remove the virus per se or attack the virus genome. The combination of peroxide and pluronic do both. The peroxide degrades both proteins and RNA
and DNA, and the pluronic also denatures proteins and dissolves the organic material into its micelle structure, completely destroying and removing the viral particles from the skin, together with other contaminants and dirt.
A 500 ml dispenser bottle contains a biphasic emulsion in two equal parts. One part of the emulsion contains f-127 pluronic acid in an oily suspension (10% w/v). Etheric oils or perfume can be added for pleasant smell. The other phase contains a water solution with hydrogen peroxide (10% v/v). Before application, the bottle is shaken vigorously and a pump with dispenser tip is used to apply the emulsion mix onto hands. The emulsion is evenly distributed over the hands as with any other sanitizer, left to work for some seconds and is then rinsed off under running tap water or simply left to air dry. There is no need to apply any soap as the liquid itself also work as a detergent. No extraordinary precautions or actions is necessary to remove the solution. The solution completely harmless after rinsing and will decompose to water, oxygen and carbon dioxide with no environmental footprint.
The remaining oils will protect the skin from drying and make it smooth.
Example 10 Application for skin sanitizing, blister-in blister pack The two-component pluronic-peroxide solution described here is intended for hand sanitizing after possible exposure to virus contamination. Virus are genetic code (RNA or DNA) wrapped in a protein envelope to protect and transmit the genetic information.
Most sanitizers only attack (denature or fix) the protein envelope so that the virus is no longer very contagious, but do not remove the virus per se or attack the virus genome. The combination of peroxide and pluronic do both. The peroxide degrades both proteins and RNA
and DNA, and the pluronic also denatures proteins and dissolves the organic material into its micelle structure, completely destroying and removing the viral particles from the skin, together with other contaminants and dirt.
A 1 ml blister pack is contained inside another 5 ml blister pack. The inner blister pack contains hydrogen peroxide (25 % v/v), the outer blister pack contains 3 ml f-127 pluronic acid in perfumed water (10 % w/v) and the first blister pack. When needed the inner blister pack is ruptured by applying manual force, then mixed by squeezing the outer pack. After mixing the outer blister pack is opened and the content is evenly distributed over the hands as with any other sanitizer, left to work for some seconds and is then rinsed off under running tap water. There is no need to apply any soap as the liquid itself also work as a detergent. The clean hands are dried off with a paper towel or air dried. No extraordinary precautions or actions is necessary to remove the solution. The solution completely harmless after rinsing and will decompose to water, oxygen and carbon dioxide with no environmental footprint or impact.
Example 11 Application for skin sanitizing, wet wipes The two-component pluronic-Peroxide solution described here is intended for hand sanitizing after possible exposure to virus contamination. Virus are genetic code (RNA or DNA) wrapped in a protein envelope to protect and transmit the genetic information.
Most sanitizers only attack (denature or fix) the protein envelope so that the virus is no longer very contagious, but do not remove the virus per se or attack the virus genome. The combination of peroxide and pluronic do both. The peroxide degrades both proteins and RNA
and DNA, and the pluronic also denatures proteins and dissolves the organic material into its micelle structure, completely destroying and removing the viral particles from the skin, together with other contaminants and dirt.
A 1 ml blister pack is contained inside another 5 ml blister pack. The inner blister pack contains hydrogen peroxide (25 % v/v), the outer blister pack contains 3 ml f-127 pluronic acid (10 % w/v) in perfumed water, a folded paper tissue and the first blister pack. When needed the inner blister pack is ruptured by applying manual force, then mixed by squeezing the pack. After mixing, the outer blister pack is opened and the folded paper tissue, now activated with the peroxide-pluronic mix used to wipe the skin, hands or contaminated surfaces free of dirt, microbes and viral contaminants. There is no need to apply any soap as the liquid itself also work as a detergent. The clean hands, skin or surface is left to dry in air.
No extraordinary precautions or actions is necessary to remove the solution.
The solution completely harmless after rinsing and will decompose to water, oxygen and carbon dioxide with no environmental footprint or harm to the skin.
Example 12 Mouth rinse application for oral sanitizing, dispenser bottle with emulsion The two-component pluronic-peroxide solution described here is intended for oral sanitizing for microbial control or during a contagious viral pandemic. Virus are genetic code (RNA or DNA) wrapped in a protein envelope to protect and transmit the genetic information. Most viral sanitizers only attack (denature or fix) the protein envelope so that the virus is no longer very contagious, but do not remove the virus per se or attack the virus genome. The combination of peroxide and pluronic does both. The peroxide degrades both proteins and RNA and DNA, and the pluronic also denatures proteins and dissolves the organic material into its micelle structure, completely destroying and removing the viral particles from the oral cavity and throat, together with other microbes, contaminants and mucus.
A 1000 ml dispenser bottle is divided in two chambers; one containing 800 milliliters of f-127 pluronic acid at 5% w/v in saline with sodium fluoride and taste and smell modifiers, and one chamber containing 200 milliliters of hydrogen peroxide 16% v/v in water. A
pump with two inlets is used to pumps liquid from both chambers into the dispenser tip for mixing and application. 10 milliliters of the mixed solution are used to rinse the mouth and throat for about 1 minute, and then spat out in the sink. There is no need to brush teeth or rinse with water after application as the liquid itself is harmless to humans, but it is no harm in doing it either. No extraordinary precautions or actions is necessary to remove the solution. The solution completely harmless after rinsing and will decompose to water, oxygen and carbon dioxide with no environmental footprint or health impact.
The mouthwash can also be used against oral infections periodontitis and peri-implantitis and tooth decay, both prophylactically and for post-surgery infection control and maintenance treatment after periodontal or implant-related procedures. It can also be used to clean toothbrushes and intra-oral devices (dentures, anti-snoring devices, orthodontic appliances etc.) to avoid re-infection from repeated use.
Example 13 Nasal/sinus rinse Nasal and sinus rinse applications, disposable bottles with applicator The two-component pluronic-peroxide solution described here is intended for nasal/sinus rinsing against a rhinoviral infection causing congestion or for virus removal during a contagious flu or corona virus pandemic. Virus are genetic code (RNA or DNA) wrapped in a protein envelope to protect and transmit the genetic information. Most viral sanitizers only attack (denature or fix) the protein envelope so that the virus is no longer very contagious, but do not remove the virus per se or attack the virus genome. The combination of peroxide and pluronic does both. The peroxide degrades both proteins and RNA and DNA, and the pluronic also denatures proteins and dissolves the organic material into its micelle structure, completely destroying and removing the viral particles from the nasal cavity and sinuses, together with other contaminants and mucus.
Fifty milliliters of hydrogen peroxide (5% v/v in saline) is added to a 250 ml disposable, soft (squeezable) bottle with nasal applicator top containing 200 milliliters of f-127 pluronic acid at 1,25% w/v in saline and mixed by vigorous shaking. The head is placed over a sink, and the bottle containing the mix is then placed against one nostril and squeezed carefully until the fluid comes out of the other nostril and goes into the sink below. The procedure is repeated until the bottle is empty. Blow the nose after application is completed. There is no need to rinse with after application, the liquid itself is harmless to humans.
No extraordinary precautions or actions is necessary to remove the solution. The solution completely harmless after rinsing and will decompose to water, oxygen and carbon dioxide with no environmental footprint or health impact.
The nasal/sinus rinse can also be used against nasal infections or against acute and chronic sinusitis. The solution can also be used both prophylactically and for post-surgery infection control after otorhinolaryngeal procedures.
The presently disclosed composition is also useful for application in pen-implant defects, and 20 the formulation may be tailored to fit with various clinical procedures, such as but not limited to treating and preventing oral infections , for maintaining oral and/or nasal health and post-operative follow-up administrations to skin, mucosa and/or oro-laryngeal and/or nasal cavities.
The presently disclosed composition can also be used for other oral procedures, such as during surgical cleaning of periodontal defects, for preparation before regenerative procedures, in periodontal maintenance treatment, in periodontitis prophylaxis (by dental hygienists), as well as in endodontics, both in root-canal procedures and in apical surgery.
What is more, the presently disclosed composition can further be used for cleaning and/or debriding outside the oral cavity, such as, but not limited to in orthopaedic revision surgery, sanitizing of transdermal devices, in dermal wound care for cleaning of acute wounds and/or in cleaning of chronic ulcers and burns.
An antimicrobial and/or anti-viral composition according to the present invention can typically be employed for use in the treatment and/or prevention of peri-implantitis, gingivitis and/or mucositis, pen-implant mucositis and/or periodontitis or for the sanitizing of the oral cavity against contagious disease or prior to oral surgery procedures.
Periimplantitis is a typical complication related to orodental rehabilitation through the use of implants, e.g., a pen-implant disease, which is well-known to the person skilled in the art as an inflammatory reaction to oral microbes in which there is an accompanied loss of the bony support of the implant. The aetiology of the disease is conditioned by the status of the tissue surrounding the implant, implant design, degree of roughness, the poor alignment of implant components, external morphology and excessive mechanical load.
The presently described antimicrobial and/or anti-viral composition offers several approaches for an effective and rapid cleaning of an implant and/or for sanitizing or decontaminate a tissue surface in the oral cavity essentially without damaging of the delicate structure or of the implant surface and/or the tissue surface itself, and essentially without leaving contaminating material residues on the treated surface.
The invention therefore in one aspect is directed to the antimicrobial and/or anti-viral composition as defined herein and/or the kit for preparing the composition of the invention as defined herein, for use as a medical device or a medicament.
Thus, the present invention relates to the use of an antimicrobial and/or anti-viral composition according to the present invention for cleaning and/or sanitizing and/or decontaminate an implant in the oral cavity, such as an implant in situ, a tissue surface in the oral cavity, such as an outer surface of a tissue in the oral cavity, a surgically exposed surface in the oral cavity, a wound in the oral cavity, such as a wound resulting from periimplantitis or a surgical wound, a periodontal defect and/or periodontal wound, and/or an oral hard tissue defect.
Implants The invention also relates to the use of the antimicrobial and/or anti-viral composition as defined herein and/or the kit for preparing the composition of the invention as defined herein, for the preparation of a medicament and/or a pharmaceutical and/or cosmetic composition, for cleaning and/or decontaminating an implant in the oral cavity, such as an implant in situ, a hard surface in the oral cavity, such as an outer surface of a hard tissue in the oral cavity, a surgically exposed hard surface in the oral cavity, a wound in the oral cavity, such as a wound resulting from periimplantitis or a surgical wound, a periodontal defect and/or periodontal wound, and/or an oral hard tissue defect.
The invention is also directed to the antimicrobial and/or anti-viral composition as defined herein or the kit for preparing the composition of the invention as defined herein for use cleaning, sanitizing, disinfecting, sterilizing and/or debriding an implant in the oral cavity, such as an implant in situ, a hard surface in the oral cavity, such as an outer surface of a hard tissue in the oral cavity, a surgically exposed hard surface in the oral cavity, a wound in the oral cavity, such as a wound resulting from periimplantitis or a surgical wound, a periodontal defect and/or periodontal wound, and/or an oral hard tissue defect.
Oro-laryngeal and nasal medical applications In dentistry and otorhinolaryngology, nasal and mouth rinses are used pre- and post-surgery to lower the microbial burden during a procedure, or to treat infections. The infection of oro-larynx and nasal mucosa leads to formation of mucus that can fill up sinuses and cause nasal and sinus congestion and microbe accumulation on tongue, tonsils, teeth and gums.
The invention is also directed to the antimicrobial and/or anti-viral composition as defined herein for use as mouth wash, nasal rinse and/or sinus rinse for the disinfection and cleaning of oral, laryngeal and/or nasal anatomical structures and/or surfaces.
Microorganisms An antimicrobial and/or anti-viral composition according to the present invention is in general intended for use in cleaning, disinfecting, sanitizing and/or decontaminating a biological surface and/or a biomaterial surface in situ, e.g. for use in removal of virus, microbes, including but not limited to bacteria, yeasts, and bacterial spores, and dirt from such a biological surface and/or a biomaterial surface in situ.
Biofilms that can be prevented, eliminated and/or treated by the composition of the present disclosure include, but are not limited to, biofilms present within the oral cavity, e.g., on the surface of teeth, on the surface of mucosal/soft-tissues such as gingivae/periodontium and inside a tooth canal (e.g. the endodontic canal).
In certain embodiments, biofilms that can be prevented, eliminated and/or treated by the composition of the present disclosure include biofilms on the urinary tract, lung, gastrointestinal tract, on and/or within chronic wounds, and present on the surface (e.g., implants) and within medical devices and medical lines, e.g., catheters, medical instruments or medical tubing.
The composition of the present disclosure can be used to reduce the growth and/or inhibit the viability of one or more microorganisms, e.g., bacteria in a biofilm. For example, and not by way of limitation, the bacteria, which can be inhibited can include Streptococcus mutctns (S. mutctns), Streptococcus sobrinus, Streptococcus sctnguis (sctnguinis), Streptococcus gordonii, Streptococcus omlis, Streptococcus mitis, Actinomyces odontolyticus, Actinomyces viscosus, Aggregcttibctcter ctctinomycetemcomitctns, lctctobctcillus spp., Porphyromoncts gin givctlis, Prevotellct intermedia, Bacteroides forsythus, Treponema denticola, Fusobacterium nucleatum, Campylobacter rectus, Eikenella corrodens, Veillonella spp., Micromonas micros, Porphyromonas cangingivalis, Haemophilus actinomycetemcomitans Actinomyces spp., Bacillus spp., Mycobacterium spp., Fusobacterium spp., Streptococcus spp., Staphylococcus aureus, Streptococcus pyogenes, Streptococcus agalectiae, Proteus mirabilis, Elebsiella pneumoniae, Acinetobacter spp., Enterococcus spp., Prevotella spp., Porphyromonas spp., Clostridium spp., Stenotrophomonas maltophilia, P.
cangingivalis, Candida albicans, Escherichia coil and/or Pseudomonas aeruginosa. In certain embodiments, the bacteria are S. mutans, which is present within biofilms found in the oral cavity, e.g., on the surface of teeth.
The microorganisms most commonly associated with implant failure are spirochetes and mobile forms of Gram-negative anaerobes. Diagnosis can be based on changes of colour in the gum, bleeding and probing depth of pen-implant pockets, suppuration, x-ray and gradual loss of bone height around the tooth. The antibiotic therapy proven to be most efficacious in the antibiogram has so far been the association of amoxycillin and clavulanic acid. In addition to bacterial infections, microbial infections in the oral cavity can of course also include fungal and/or viral infections.
An antimicrobial and/or anti-viral composition according to the present invention is effective for killing bacteria, fungus and/or virus.
Typically, a composition according to the present invention is for use in cleaning skin and/or mucosa from virus such as, but not limited to, Riboviria, such as Coronaviridae, such as Orthocoronavirinae and Orthomyxoviridae such as Influenza A, B, C and D virus, Arbo virus and lsavirus, and such as Rotavirus, Noro virus, Adenovirus, Papillomavirus, Herpes virus, Hepatitis virus, Small Pox virus, Parvo virus, Ebola virus, Measles virus or Rabies virus.
In a presently preferred aspect, a composition according to the present invention is for use in cleaning skin and/or mucosa from Coronavirus or Influenza virus.
What is more, the composition described herein is antimicrobial, without causing microbial resistance, as well as anti-viral.
In consequence, the present invention relates to a method for cleaning, sanitizing, treating and /or preventing contagious diseases, infections, gingivitis and/or mucositis, pen-implant mucositis, peri-implantitis, periodontitis, tooth decay, and/or sinusitis and rhinitis, comprising cleaning of a biological surface and/or a biomaterial surface in situ by applying a composition according to the present invention to said fouled, filmed and/or contaminated structure, tissue or surface.
EXAMPLES
The following Examples have been included to provide guidance to one of ordinary skill in the art for practicing representative embodiments of the presently disclosed subject matter.
Considering the present invention and the general level of skill in the art, those of skill can appreciate that the following Examples are intended to be exemplary only and that numerous changes, modifications, and alterations can be employed without departing from the scope of the presently disclosed subject matter.
Example 1 Analysis of micelle formation of pluronic in presence of peroxide Pluronic F-127 added to an aqueous solution can change its thickness depending on the concentration and temperature. F-127 is a non-ionic, surfactant polyol with a molecular weight of 12500 Daltons.
As can be seen in figure 1, gel boundaries for aqueous saline (physiological conditions) solutions of copolymer F-127. The filled circles are data points obtained by the tube inversion method for the mixture. The unfilled squares are data points from rheometric analyses. The chart clearly indicates that pluronic concentrations below 15% w/v in saline remains fluid independent of temperature. Fluid pluronic solutions form independent micelles, but the concentration is not high enough for the pluronic micelles to assemble into a cubic gel. Thus, low pluronic concentrations that allow for micelle formation but stay liquid and act as detergent may be good for tissue-friendly cleaning of biological surfaces, but addition of other potent reactants that can contribute to the decontamination is expected to completely disrupt the micelle formation and thus abolish the wanted detergent and denaturing effects.
Adding Peroxide to the Pluronic f-127 gel In order to test if micelle formation (as visualised by ability to foaming and dissolve oil) still could be obtained when mixing low concentration of Pluronic f-127 in water with various antimicrobial agents (see example 3), hydrogen peroxide, in a wide range of peroxide concentrations, was tested (Table 1).
The technique used for making aqueous poloxamer solution is simple. Weighed amount of the f-127 is slowly added to a known weight of cold water (less than 10 C) with careful stirring.
The stirring rate should be controlled so as to maintain a slight vortex in the liquid. Too rapid a stirring rate will cause aeration and the formation of foam.
Sample Pluronic F-127(gr) H20 (ml) 50% H202(m1) 0 2.5 50.00 0.00 (0.0%) 1 2.5 49.90 0.10 (0.1%) 2 2.5 49.50 0.50 (0.5%) 3 2.5 49.00 1.00 (1.0%) 4 2.5 48.50 1.50 (1.5%) 5 2.5 47.00 3.00 (3.0%) 6 2.5 44.00 6.00 (6.0%) 7 2.5 38.00 12.00 (12.0%) Table 1: Compositions of suspensions containing 5% pluronic Acid F-127 (Zigma Aldrich) in water and a range of Hydrogen Peroxide (Sigma Aldrich). After dissolving the f-127 in cold water, the right amount of hydrogen peroxide was added, mixing was done by inverting tubes 5 carefully to avoid foaming, and the solutions were left on the bench at room temperature for 10 minutes. When all the polymer has been added, stirring can be continued (while keeping the solution cool) until a clear solution is formed or the container can be placed in a refrigerator and left undisturbed for several hours, at which time solution is complete.
The H202 was mixed in by slight stirring for a few seconds when the experiment started.
Sample Foaming (0-3) Oil absorption per % of H202 50 ml (droplets) 0 3 7 0.00 1 2 6 0.1%
2 3 12 0.5%
3 3 11 1.0%
4 3 7 1.5%
5 2 5 3.0%
6 1 2 6.0%
7 1 0 12.0%
Table 2: After incubation all the solutions were still liquid (no gel formation as expected) and were vortexed and the ability to form foam (as a simple measurement of surfactant effect) was scored on a scale from 0 (no foam) to three (much foam). As expected, sample 0 scored maximum, and addition of hydrogen peroxide reduced foaming at low and high concentration.
Unexpectedly there were no linearity in the reduction of foaming. In fact, samples 2 trough 4 scored as high as the control, indicating that micelle formation and surfactant effect were preserved in these samples. The samples were then tested on how many oil droplets (mineral oil stained with oil red (Sigma Aldrich)) from a needle point the solutions could absorbed before getting turbid. Turbidity is a sign of macro-emulsion, a stage where oil droplets become so big that they disperse light. The positive control, Sample 0, absorbed 7 oil droplets before getting turbid. The negative control, sample 7, turned turbid with the first droplet.
The expected linearity between these extremes was however not observed. Surprisingly, sample 2 (0.5%
Peroxide) and 3 (1.0% peroxide) actually absorbed almost twice as many droplets than the positive control before turbidity was observed. This indicates that Pluronic f-127 micelle formation at low concentrations (=liquid solutions) actually is more efficient, and dynamic, in presence of low concentrations of hydrogen peroxide in the range of 0,5 ¨ 1,5%
volume by volume (in a 5% w/v solution of f-127).
Example 2 Test of biocompatibility of pluronic acid combined with peroxide Test procedure:
The biocompatibility test was performed according to ISO 10993-5:2009 Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity.
Colorimetric assay such MTT, WST-1 or LDH was not used as the peroxide suspension degrade the indicator colour used in these assays and thus, they cannot be used. Instead radioactive labelling with [3H] thymidine incorporation was used to analyse the cytotoxicity of the pluronic-peroxide solution on normal human dermal fibroblast cells (NHDF) (Lonza Walkersville, Inc. Walkersville, MD, USA).
Due the viscosity of the tested hydrocolloid gels (SilvaSorb0 Gel, Medline Industries, Munedelein, IL) and the pluronic-Peroxide gels (20%Pluronic f-127 in water with 3%
Hydrogen Peroxide), the test samples could not be diluted into the cell culture medium. Nor could the NHDF cells grow directly onto the gel due their lack of surface properties. To overcome this problem, the NHDF cells were grown on cell culture inserts (Millice110, Millipore Corp., Billerica, MA, USA) that was inserted into a well that contained the test gel diluted 1:1 against cell culture medium. The NHDF cells were cultivated in 24 well plates for 24 hours at 37C and 5% CO2 with Dulbecco's PBS cell culture media (FGM0-2 with Insulin (CC-4021J), rhFGF-B (CC-4065J) and FBS (CC-4161J), Lonza Walkervill, MD USA).
After 24 hours growing in presence of test substances or controls (no gel and gelatin gel) 0.5 pL
3H-thymidine (Perkin Elmer, Boston, USA) was added into the wells containing the cells. After 12 hours of exposure to thymidine the cells were washed three times in cold PBS and lysed with 250pL 1M NaOH. Then 200pL of the solubilized cell solution was transferred to 3m1 Insta-gel-2-Pluss liquid scintillation fluid. Subsequently the scintillations were counted in a liquid scintillation analyser (TRI-Corb0 1500 Perkin Elmer).
Results and conclusion: There were no observed difference in count number between samples exposed to pluronic-Peroxide solution and the controls indicating that the NHDF
cells grew at normal rate in presence of these test gels. The hydrogen peroxide containing pluronic acid gels are safe and biocompatible. The SilvaSorb gel showed a significant decrease in count number indication slower cell growth in presence of this gel as has also been repeatedly reported in the scientific literature, indicating that this gel is slightly toxic NHDF cells.
Example 3 Chemical cleaning efficacy of liquid Pluronic f-127 solutions containing peroxide The following cleaning solutions were tested:
Negative control Brain Heart Infusion Broth (BHI broth) Test 1 H202 3% v/v + f-127 1% w/v Test 2 H202 5% v/v + f-127 1% w/v Test 3 H202 3% v/v + f-127 7% w/v Test 4 H202 5% v/v + f-127 7% w/v Test 5 Chlorhexidine 0.2% w/v + f-127 7% w/v Test 6 Ethanol 75% v/v + f-127 1% w/v Experimental set-up:
A stock Streptococcus Epidermidis culture was established in BHI broth and allowed to grow to log phase.
The S. Epidermidis culture was introduced to cell culture disks of c.p.
titanium and allowed to for a multilayer biofilm on the surface over a period of 2 days. After the biofilm had been established, the discs were rinsed several times in sterile, cold PBS until only adherent cells was present on the surfaces.
The discs with biofilm on were then submerged in test gel or control for 5 minutes 5 sec.
making sure that the entire discs were covered by the test gels all the time.
The discs were then rinsed for 10 minutes in cold PBS on a shaker, rinsed off and viewed in a table-top scanning electron microscope to see how many bacteria that were left on the test surfaces.
Results and conclusion:
This experiment showed that cleaning efficacy increased some with increasing H202 and increasing Pluronic f-127 concentration. The difference between test 1 and test 4 was however surprisingly small and not statistically significant, as all four tests performed very well and almost no bacteria remained on the surface. The negative control was as expected completely covered by bacteria with no effect of the PBS washing. The positive Chlorhexidine and Ethanol controls was surprisingly ineffective. Almost all of the biofilm was retained on the surfaces in these two groups. Later analysis with regrowth of bacteria from these surfaces revealed that all bacteria in these two tests were dead, but that the bulk of the biofilm remained attached to the surface, forming a contaminated layer that provide a strong bridgehead for new biofilm formation if a new contamination occurs.
The surprising finding in this study is that it seems to be a synergistic effect between hydrogen peroxide and Pluronic f-127 that not only kills bacteria but also disintegrate and solubilize the entire biofilm, leaving an almost totally decontaminated surface (Figure3). The concentration of the peroxide and pluronic can be reduced toward 3% hydrogen peroxide in 1% pluronic acid without losing much effect compared to stronger solutions.
This also indicates that the synergy between hydrogen peroxide and pluronic acid can be fine-tuned and probably has an optimal concentration-relation that allows for rapid and dynamic micelle (detergent and denaturation) effect and at the same time maintains the effectiveness of activated oxygen release that kills microbes and dissolves organic molecules.
This optimal formulation appears to be lower in concentration of both peroxide and pluronic when the components are mixed together than what one would expect based on the effect of the separate components.
As is shown in Figure 3, titanium surfaces contaminated with S. Epidermidis bacteria was cleaned with growth medium (BHI, Negative control), H202 5% v/v + f-127 1% w/v (Test 2), H202 5% v/v + f-127 7% w/v (Test 4), Chlorhexidine 0,2% w/v + f-127 7% w/v (Test 5) or Ethanol 75% v/v + f-127 1% w/v. The negative control did not remove the bacteria, nor was the bacteria destroyed. The peroxide + pluronic acid mix killed all bacteria, dissolved the biofilm and removed the debris almost completely (Tests 2 & 4). Test 4 was slightly, but not statistically significant, more effective than Test 2. Chlorhexidine (Test 5) and Ethanol (Test 6) did kill most of the bacteria but did not remove any debris from the surface, leaving the surfaces heavily contaminated. Surfaces visualized after cleaning in a scanning electron microscope. Scale bar is 20 micrometres.
Example 4 Staining of living and dead bacteria on decontaminated surfaces Titanium surfaces contaminated with S. Epidermidis bacteria and grown to biofilm in BHI
broth was removed from growth medium and submerged in sanitizing solution for 5 minutes on a slow shaker. Discs were sanitized with A) saline (Negative control), B) Chlorhexidine 0.2% w/v, or C) H202 3% v/v + f-127 pluronic Acid 5% w/v. After cleaning the surfaces were stained with fluorescent dyes, green for living microbes and red for dead microbes. The negative control (saline) did not remove any of the microbes, nor was the biofilm removed.
The chlorhexidine killed all microbes but left the dead cells to contaminate the surface. The hydrogen peroxide + pluronic acid mix killed all microbes, dissolved the biofilm and removed the contamination almost completely. Surfaces were visualized in a confocal microscope after cleaning and staining (Figure 4).
Example 5 Regrowth of S. Epidermidis after sanitizing a contaminated titanium surface Regrowth of S. Epidermidis bacteria harbouring the luciferase gene making them fluorescent, on sanitized titanium surfaces. Surfaces was first contaminated with bacteria and incubated in BHI broth until the surfaces were completely covered in biofilm. The titanium discs were then submerged in sanitizing solution and left on a slow shaker for 5 minutes. After sanitizing the discs were rinsed in a large volume of sterile water, then covered by BHI medium again and incubated at 37 centigrade. At hourly intervals the discs were placed in a fluorometer to measure regrowth of bacteria by amount of fluorescent as compared to an untreated calibrated control and a sterile disc. The results show (see figure 5B) that D) water with detergent (SDS 0,1% w/v), E) water with 5% pluronic acid and F) saline had minimal sanitizing effect, as regrowth of the biofilm occurred within 3-4 hours after cleaning. Chlorhexidine, 0,2%, on the other hand killed all bacteria with no regrowth observed although the dead biofilm stuck and remained on the surface (see figure 3 and 4).
Hydrogen peroxide, 5% v/v, alone (A) cleaned the surface well as seen by a delay of about 13 hours before the biofilm restored itself. However, hydrogen peroxide 3% v/v combined with 5% pluronic acid in water cleaned the surface significantly better, delaying regrowth with more than 15 hours (see also Figure 5A).
Example 6 Pluronic with peroxide is more skin-friendly than an alcohol containing hand-sanitizer Left and right thumbs were washed and sanitized four times daily for five consecutive days with a mix of A) pluronic acid (5% w/v) and hydrogen peroxide (3% v/v) or B) Antibac PharmaTM containing ethanol and propan-2-ol respectively. After completion of the 5th day sanitizing procedure both fingers were stained with a solution of Indian Red (iron oxide) to visualize fissures and cracks in the skin. After staining the fingers were washed thoroughly in warm water with soap, left to air dry and photographed in daylight. Fissures and cracks in the skin of the thumbs are easily visible as striated brown staining. The Antibac PharmaTM
treated finger show deep fissures and cracks with callous, dry and hard skin.
The pluronic-peroxide formulation however, caused no harm to the skin of the left thumb, leaving skin intact and tender. This demonstrate that the pluronic-peroxide formulation is more biocompatible and tissue friendly than alcohol-based hand sanitizers (Figure 6).
Example 7 Efficiency of sanitizing solutions on removing organic contaminants To demonstrate the ability of hand sanitizers and cleaning solutions to remove stains and contamination from skin, a panel of products and solutions were tested against stains of permanent ink. Fingers were marked with a line of permanent blue ink (LyrecoTM
permanent marker for laboratory use). The ink was applied with a pen and left to air-dry for approx. 5 minutes. The fingers were then cleaned with the various sanitizing solutions for about 6-8 seconds, mimicking the normal application time for hand sanitizers in daily life. The sanitizing agent was thoroughly wiped off with paper tissue and the fingers were photographed with an iPhone X in daylight using the automatic exposure control. The 5 intensity of the remaining stain is regarded to be an inverse visual gauge for the cleaning efficacy of the tested solutions. Finger A) was washed only with water. Finger B) was cleaned with warm water and soap. Finger C) was cleaned with 0.2%
chlorhexidine and finger D) was rinsed with PyrispetTM (0.1% cetyl-pyridinium chloride). Finger E) was cleaned with Antibac PharmaTM (Alcohol based sanitizer containing ethanol and propan-2-ol), finger 10 F) was cleaned with bleach (4% Sodium hypochlorite). Finger G) and H) was rinsed with hydrogen peroxide (1% and 5% v/v in water respectively). Finger I) was washed in a solution of pluronic acid f-127 in water (5% w/v). Finger J) was sanitized with a mix of pluronic acid (5% w/v) and hydrogen peroxide (1% v/v). The results show that bleach and hydrogen peroxide is very effective in removing the permanent ink stain. However, surprisingly, the 15 most efficient removal of the stain is obtained by the combination of pluronic acid and weak hydrogen peroxide (Figure 7).
Example 8 Application for skin sanitizing, two-chamber dispenser bottle.
20 The two-component pluronic-Peroxide solution described here is intended for hand sanitizing after possible exposure to virus contamination. Virus are genetic code (RNA or DNA) wrapped in a protein envelope to protect and transmit the genetic information.
Most sanitizers only attack (denature or fix) the protein envelope so that the virus is no longer very contagious, but do not remove the virus per se or attack the virus genome. The combination 25 of peroxide and pluronic do both. The peroxide degrades both proteins and RNA and DNA, and the pluronic also denatures proteins and dissolves the organic material into its micelle structure, completely destroying and removing the viral particles from the skin, together with other contaminants and dirt.
30 A 500 ml dispenser bottle is divided in two chambers; one containing 400 milliliters of f-127 pluronic acid at 10% w/v in water, and one chamber containing 100 milliliters of Hydrogen Peroxide 25% v/v in water. A pump with two inlets pumps liquid from both chambers into the dispenser tip for mixing and application. The mixed solution is evenly distributed over the hands as with any other sanitizer, left to work for some seconds and is then rinsed off under running tap water. There is no need to apply any soap as the liquid itself also work as a detergent. The clean hands are dried off with a paper towel or air dried. No extraordinary precautions or actions are necessary to remove the solution. The solution is completely harmless after rinsing and will decompose to water, oxygen and carbon dioxide with no environmental footprint or impact.
Example 9 Application for skin sanitizing, dispenser bottle with emulsion.
The two-component pluronic-peroxide solution described here is intended for hand sanitizing after possible exposure to virus contamination. Virus are genetic code (RNA or DNA) wrapped in a protein envelope to protect and transmit the genetic information.
Most sanitizers only attack (denature or fix) the protein envelope so that the virus is no longer very contagious, but do not remove the virus per se or attack the virus genome. The combination of peroxide and pluronic do both. The peroxide degrades both proteins and RNA
and DNA, and the pluronic also denatures proteins and dissolves the organic material into its micelle structure, completely destroying and removing the viral particles from the skin, together with other contaminants and dirt.
A 500 ml dispenser bottle contains a biphasic emulsion in two equal parts. One part of the emulsion contains f-127 pluronic acid in an oily suspension (10% w/v). Etheric oils or perfume can be added for pleasant smell. The other phase contains a water solution with hydrogen peroxide (10% v/v). Before application, the bottle is shaken vigorously and a pump with dispenser tip is used to apply the emulsion mix onto hands. The emulsion is evenly distributed over the hands as with any other sanitizer, left to work for some seconds and is then rinsed off under running tap water or simply left to air dry. There is no need to apply any soap as the liquid itself also work as a detergent. No extraordinary precautions or actions is necessary to remove the solution. The solution completely harmless after rinsing and will decompose to water, oxygen and carbon dioxide with no environmental footprint.
The remaining oils will protect the skin from drying and make it smooth.
Example 10 Application for skin sanitizing, blister-in blister pack The two-component pluronic-peroxide solution described here is intended for hand sanitizing after possible exposure to virus contamination. Virus are genetic code (RNA or DNA) wrapped in a protein envelope to protect and transmit the genetic information.
Most sanitizers only attack (denature or fix) the protein envelope so that the virus is no longer very contagious, but do not remove the virus per se or attack the virus genome. The combination of peroxide and pluronic do both. The peroxide degrades both proteins and RNA
and DNA, and the pluronic also denatures proteins and dissolves the organic material into its micelle structure, completely destroying and removing the viral particles from the skin, together with other contaminants and dirt.
A 1 ml blister pack is contained inside another 5 ml blister pack. The inner blister pack contains hydrogen peroxide (25 % v/v), the outer blister pack contains 3 ml f-127 pluronic acid in perfumed water (10 % w/v) and the first blister pack. When needed the inner blister pack is ruptured by applying manual force, then mixed by squeezing the outer pack. After mixing the outer blister pack is opened and the content is evenly distributed over the hands as with any other sanitizer, left to work for some seconds and is then rinsed off under running tap water. There is no need to apply any soap as the liquid itself also work as a detergent. The clean hands are dried off with a paper towel or air dried. No extraordinary precautions or actions is necessary to remove the solution. The solution completely harmless after rinsing and will decompose to water, oxygen and carbon dioxide with no environmental footprint or impact.
Example 11 Application for skin sanitizing, wet wipes The two-component pluronic-Peroxide solution described here is intended for hand sanitizing after possible exposure to virus contamination. Virus are genetic code (RNA or DNA) wrapped in a protein envelope to protect and transmit the genetic information.
Most sanitizers only attack (denature or fix) the protein envelope so that the virus is no longer very contagious, but do not remove the virus per se or attack the virus genome. The combination of peroxide and pluronic do both. The peroxide degrades both proteins and RNA
and DNA, and the pluronic also denatures proteins and dissolves the organic material into its micelle structure, completely destroying and removing the viral particles from the skin, together with other contaminants and dirt.
A 1 ml blister pack is contained inside another 5 ml blister pack. The inner blister pack contains hydrogen peroxide (25 % v/v), the outer blister pack contains 3 ml f-127 pluronic acid (10 % w/v) in perfumed water, a folded paper tissue and the first blister pack. When needed the inner blister pack is ruptured by applying manual force, then mixed by squeezing the pack. After mixing, the outer blister pack is opened and the folded paper tissue, now activated with the peroxide-pluronic mix used to wipe the skin, hands or contaminated surfaces free of dirt, microbes and viral contaminants. There is no need to apply any soap as the liquid itself also work as a detergent. The clean hands, skin or surface is left to dry in air.
No extraordinary precautions or actions is necessary to remove the solution.
The solution completely harmless after rinsing and will decompose to water, oxygen and carbon dioxide with no environmental footprint or harm to the skin.
Example 12 Mouth rinse application for oral sanitizing, dispenser bottle with emulsion The two-component pluronic-peroxide solution described here is intended for oral sanitizing for microbial control or during a contagious viral pandemic. Virus are genetic code (RNA or DNA) wrapped in a protein envelope to protect and transmit the genetic information. Most viral sanitizers only attack (denature or fix) the protein envelope so that the virus is no longer very contagious, but do not remove the virus per se or attack the virus genome. The combination of peroxide and pluronic does both. The peroxide degrades both proteins and RNA and DNA, and the pluronic also denatures proteins and dissolves the organic material into its micelle structure, completely destroying and removing the viral particles from the oral cavity and throat, together with other microbes, contaminants and mucus.
A 1000 ml dispenser bottle is divided in two chambers; one containing 800 milliliters of f-127 pluronic acid at 5% w/v in saline with sodium fluoride and taste and smell modifiers, and one chamber containing 200 milliliters of hydrogen peroxide 16% v/v in water. A
pump with two inlets is used to pumps liquid from both chambers into the dispenser tip for mixing and application. 10 milliliters of the mixed solution are used to rinse the mouth and throat for about 1 minute, and then spat out in the sink. There is no need to brush teeth or rinse with water after application as the liquid itself is harmless to humans, but it is no harm in doing it either. No extraordinary precautions or actions is necessary to remove the solution. The solution completely harmless after rinsing and will decompose to water, oxygen and carbon dioxide with no environmental footprint or health impact.
The mouthwash can also be used against oral infections periodontitis and peri-implantitis and tooth decay, both prophylactically and for post-surgery infection control and maintenance treatment after periodontal or implant-related procedures. It can also be used to clean toothbrushes and intra-oral devices (dentures, anti-snoring devices, orthodontic appliances etc.) to avoid re-infection from repeated use.
Example 13 Nasal/sinus rinse Nasal and sinus rinse applications, disposable bottles with applicator The two-component pluronic-peroxide solution described here is intended for nasal/sinus rinsing against a rhinoviral infection causing congestion or for virus removal during a contagious flu or corona virus pandemic. Virus are genetic code (RNA or DNA) wrapped in a protein envelope to protect and transmit the genetic information. Most viral sanitizers only attack (denature or fix) the protein envelope so that the virus is no longer very contagious, but do not remove the virus per se or attack the virus genome. The combination of peroxide and pluronic does both. The peroxide degrades both proteins and RNA and DNA, and the pluronic also denatures proteins and dissolves the organic material into its micelle structure, completely destroying and removing the viral particles from the nasal cavity and sinuses, together with other contaminants and mucus.
Fifty milliliters of hydrogen peroxide (5% v/v in saline) is added to a 250 ml disposable, soft (squeezable) bottle with nasal applicator top containing 200 milliliters of f-127 pluronic acid at 1,25% w/v in saline and mixed by vigorous shaking. The head is placed over a sink, and the bottle containing the mix is then placed against one nostril and squeezed carefully until the fluid comes out of the other nostril and goes into the sink below. The procedure is repeated until the bottle is empty. Blow the nose after application is completed. There is no need to rinse with after application, the liquid itself is harmless to humans.
No extraordinary precautions or actions is necessary to remove the solution. The solution completely harmless after rinsing and will decompose to water, oxygen and carbon dioxide with no environmental footprint or health impact.
The nasal/sinus rinse can also be used against nasal infections or against acute and chronic sinusitis. The solution can also be used both prophylactically and for post-surgery infection control after otorhinolaryngeal procedures.
Claims (23)
1. A composition, comprising an antimicrobial and/or anti viral mixture consisting of:
(a) H202 at a final concentration of between 3.0 ¨ 7.0%v/v, and 5 (b) a poloxamer at a concentration of 0.1- 10.0%w/v.
(a) H202 at a final concentration of between 3.0 ¨ 7.0%v/v, and 5 (b) a poloxamer at a concentration of 0.1- 10.0%w/v.
2. The composition according to claim 1, wherein the poloxamer is at a concentration of 1.0-5.0%w/v.
3. The composition according to claim 2, wherein the poloxamer is at a concentration of at the most 5.0%w/v.
10 4. The composition according to any of the preceding claims, wherein the component (b) is a composite hydrogel formulation.
5. The composition according to any of the preceding claims, wherein the poloxamer is a mixture of poloxamers.
6. The composition according to any of the preceding claims, wherein the 15 component (b) is selected from the group consisting of pluronic acid, Pluronic F-127 and Poloxamer 407.
7. The composition according to any of the preceding claims, wherein the H202 of component (a) has a final concentration of 3.0%v/v.
8. The composition according to any of the preceding claims, wherein 20 component (a) and component (b) are provided in a 1:1 ratio.
9. The composition according to any of the preceding claims, further comprising water and/or physiological saline.
10. The composition according to any of the preceding claims, wherein components:
25 (a) H202, and (b) a poloxamer, are kept separate from each other until use.
25 (a) H202, and (b) a poloxamer, are kept separate from each other until use.
11. The composition according to any of the preceding claims, further comprising an additional bioactive substance.
30 12. The composition according to claim 11, wherein the bioactive substance is selected from the group consisting of EMD, peptides, drugs, bioactive ions like fluoride, small molecules, radioactive molecules, antimicrobial molecules and radio-opaque molecules or any combination thereof.
13. The composition according to any of the preceding claims, further comprising 35 an additional antimicrobial substance.
14. The composition according to any of the preceding claims, wherein the composition has a shelf-life of at least 1 years at room temperature.
15. A method of sanitizing, sterilizing, disinfecting and/or decontaminating a biological surface and/or a biomaterial surface comprising applying the composition according to any one of claims 1-14 to a biological surface and/or a biomaterial surface.
16. A method of cleaning skin and/or mucosa of a subject from microbes comprising applying the composition according to any one of claims 1-14 to the skin and/or mucosa of a subject.
17. The method according to any one of claims 15 and 16, wherein the microbes comprise bacteria or virus or both.
18. The method according to claim 17, wherein the microbes comprise Riboviria,
19. The method according to claim 17, wherein the microbes comprise Coronaviridae, Orthomyxoviridae, Caliciviridae or Reoviridae or any combination thereof.
20. The method according to claim 17, wherein the microbes comprise Orthocoronavirinae.
21. The method according to claim 17, wherein the microbes comprise Coronavirus, Rotavirus, Norovirus or Influenza virus type A, B, C or D or any combination thereof.
22. The method according to claim 17, wherein the microbes comprise Sars-Cov-2.
23. The composition of to any of claims 1-14, wherein said composition is incorporated into a hand wash, oral wash, nasal cleansing solution, sinus cleansing solution, or skin cleansing solution.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20164065.3 | 2020-03-18 | ||
EP20164065.3A EP3881901A1 (en) | 2020-03-18 | 2020-03-18 | Improved liquid composition for cleaning, sanitizing and/or disinfecting |
US202016840921A | 2020-04-06 | 2020-04-06 | |
US16/840,921 | 2020-04-06 | ||
PCT/EP2021/057024 WO2021186000A1 (en) | 2020-03-18 | 2021-03-18 | Improved liquid composition for cleaning, sanitizing and/or disinfecting |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3170947A1 true CA3170947A1 (en) | 2021-09-23 |
Family
ID=74884978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3170947A Pending CA3170947A1 (en) | 2020-03-18 | 2021-03-18 | Liquid composition of h2o2 and a poloxamer for cleanining,sanitizing,and/or disinfecting |
Country Status (7)
Country | Link |
---|---|
JP (1) | JP2023518701A (en) |
KR (1) | KR20230006463A (en) |
CN (1) | CN115605269A (en) |
AU (1) | AU2021238760A1 (en) |
BR (1) | BR112022018324A2 (en) |
CA (1) | CA3170947A1 (en) |
WO (1) | WO2021186000A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102613224B1 (en) | 2023-05-19 | 2023-12-12 | 국방과학연구소 | Detoxification method of biological agents |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6254857B1 (en) * | 2000-05-24 | 2001-07-03 | Colgate-Palmolive Company | Effervescent whitening dentifrice having oxygen-derived sensory signal |
MY128134A (en) * | 2000-09-28 | 2007-01-31 | Novartis Ag | Compositions and methods for cleaning contact lenses |
WO2005030172A1 (en) * | 2003-09-24 | 2005-04-07 | The Regents Of The University And Methods | Antimicrobial nanoemulsion compositions and methods |
CA2533950C (en) * | 2005-01-28 | 2013-10-22 | B. Braun Medical Ag | Virucidal disinfectant |
US8377421B2 (en) * | 2005-11-07 | 2013-02-19 | Martin S. Giniger | Tooth glossing or finishing compositions for oral care |
WO2007066837A1 (en) * | 2005-12-06 | 2007-06-14 | Lg Household & Health Care Ltd. | Delivery system for tooth whitening component using in situ gelling |
US20100179368A1 (en) * | 2008-11-07 | 2010-07-15 | Aries Associates, Inc. | Novel Chemistries, Solutions, and Dispersal Systems for Decontamination of Chemical and Biological Systems |
US20120039821A1 (en) * | 2010-08-13 | 2012-02-16 | Robell Research, Inc. | Dental Activating Gel |
SG10201801848UA (en) * | 2013-09-11 | 2018-04-27 | Glenn Abrahmsohn | Hypertonic antimicrobial therapeutic compositions |
TR201617080A2 (en) * | 2016-11-23 | 2018-06-21 | Univ Yeditepe | AN PEST REMOVER ANTIMICROBIAL COMPOSITION |
-
2021
- 2021-03-18 BR BR112022018324A patent/BR112022018324A2/en unknown
- 2021-03-18 CA CA3170947A patent/CA3170947A1/en active Pending
- 2021-03-18 CN CN202180033519.8A patent/CN115605269A/en active Pending
- 2021-03-18 JP JP2022554494A patent/JP2023518701A/en active Pending
- 2021-03-18 KR KR1020227035200A patent/KR20230006463A/en unknown
- 2021-03-18 AU AU2021238760A patent/AU2021238760A1/en active Pending
- 2021-03-18 WO PCT/EP2021/057024 patent/WO2021186000A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2021186000A1 (en) | 2021-09-23 |
CN115605269A (en) | 2023-01-13 |
BR112022018324A2 (en) | 2022-11-22 |
KR20230006463A (en) | 2023-01-10 |
JP2023518701A (en) | 2023-05-08 |
AU2021238760A1 (en) | 2022-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7486557B2 (en) | Semi-solid composition for preventing bacterial contamination - Patents.com | |
CA2606734A1 (en) | Method of using oxidative reductive potential water solution in dental applications | |
Brookes et al. | Antimicrobial Mouthwashes: An Overview of Mechanisms—What Do We Still Need to Know? | |
CA3170947A1 (en) | Liquid composition of h2o2 and a poloxamer for cleanining,sanitizing,and/or disinfecting | |
US20230020320A1 (en) | Liquid Composition for Cleaning, Sanitizing and/or Disinfecting | |
US10226403B2 (en) | Composition and method for using medicament for endodontic irrigation, stem cell preparation and tissue regeneration | |
JP7467445B2 (en) | Compositions and methods for treating transient biofilms | |
US20230056514A1 (en) | Multi-Functional Cleaning and/or Debridement Composition | |
US20150140516A1 (en) | Composition and Method for Using Medicament for Endodontic Irrigation, Stem Cell Preparation and Tissue Regeneration | |
ABUELQOMSAN | A Review of Root Canal Irrigants-Their Indications, Uses and Interactions. | |
KR20020066060A (en) | Composition of microbicide for disinfecting a toothbrush, Method for manufacturing the composition, and Method for disinfecting a toothbrush using the composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20220907 |
|
EEER | Examination request |
Effective date: 20220907 |
|
EEER | Examination request |
Effective date: 20220907 |
|
EEER | Examination request |
Effective date: 20220907 |
|
EEER | Examination request |
Effective date: 20220907 |
|
EEER | Examination request |
Effective date: 20220907 |
|
EEER | Examination request |
Effective date: 20220907 |